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Hematopoiesis is a program for blood formation and is characterized by ventral 
mesoderm induction, hematopoietic stem cell specification and subsequent lineage cell 
differentiation. This program is highly conserved during evolution. Many key regulators 
have been identified through the studies in mouse, amphibians and birds. Recently, 
zebrafish (Danio rerio) has emerged as a good genetic model organism to study the 
early events and organogenesis during vertebrate development. The hematopoiesis in 
zebrafish has been shown to be very similar to that in mammals and other higher 
vertebrates. Almost all analogous blood cells have been identified in zebrafish and early 
hematopoietic events, like blood circulation and heart beating, can be visualized under 
the microscope after 24 hours post fertilization. In addition, unlike mouse, zebrafish early 
blood deficient mutants can survive up to 7 days post fertilization with normal body 
formation, which facilitate the in-depth study of early hematopoiesis during vertebrate 
development. Hence, complementary to mouse, zebrafish is a good vertebrate model 
system for the study of hematopoiesis. 
Many zebrafish hematopoietic mutants have been identified through large-scale genetic 
screens. However, specific tissue or organ deficient mutants can not be isolated through 
these morphology-based screens. In order to study the T-cell development and thymic 
organogenesis, we carried out the whole mount in situ based forward genetic screen 
using rag1 as a marker. After one year of primary screening and two rounds of 
re-screens, we identified 86 rag1 deficient mutant families from 540 mutagenized 
genomes. Considering the criterions of general development, blood circulation and 
thymus rudiment marker foxn1 expression, 13 mutants were selected and maintained for 
future study.  
 vi
In addition to using forward genetic approach, we also used microarray techniques to 
compare the gene expression profiles between wild-type and early hematopoietic mutant, 
cloche, which has defects in both hematopoietic and vascular development. I developed 
a method to construct cDNA library from a single embryo of any desired development 
stage. Through this method, we could compare the gene expression profile of cloche 
mutant and wild-type at very early stage. We performed Affymetrix Array on cloche 
mutants at 18-somite stage and identified 18 previously uncharacterized zebrafish genes 
that were down-regulated in the cloche mutant. Further whole mount in situ analyses 
showed that 9 of these genes had tissue specific expression patterns in hematopoietic or 
vascular cells.  
Through our forward genetic screening and microarray analyses, many hematopoietic 
mutants and hematopoietic or vascular related genes have been identified. Collectively, 
the mutants will serve as invaluable models and the genes as potential molecular 
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1 Chapter I:  Introduction 
 
1.1 Hematopoiesis Program in Vertebrate 
1.1.1 General Concepts of Hematopoiesis 
The blood is composed of a large array of cell types that circulate through the blood 
vessels to reach different tissues, where they provide oxygen (erythrocytes), produce 
platelets that are essential for clotting processes (megakaryocytes), supply the first 
barrier of defense against invasive pathogens (macrophages and neutrophils), and 
produce the specific protection system against foreign agents and abnormal cells 
(lymphoid lineage-T cells, B cells and natural killer cells). All these mature blood cells 
come from a common progenitor cell called hematopoietic stem cell (HSC), which can 
differentiate into multiple blood cell types and maintain the self-renewal activity (Kondo 
et al., 2003). The processes that HSC commit and differentiate to all blood lineage cells 
are defined as hematopoiesis.  
1.1.2 The Ontogeny of Hematopoiesis 
The development of hematopoiesis has been studied in many species, and several 
aspects of the program are conserved throughout vertebrate evolution. The initiation of 
hematopoiesis is ventral mesoderm induction conducted by bone morphogenic protein 
(BMP-4) and some other unknown growth factors (Kishimoto et al., 1997; Winnier et al., 
1995). Following this induction, blood cells development occurs in two waves: the first 
wave of hematopoiesis arise in the blood island of yolk sac and leads to the production 
of primitive red blood cells, megakaryocytes, and macrophage progenitors (Maximow 
AA., 1909; Xu et al., 2001; Palis et al., 1999); the second hematopoietic wave (definitive 
wave of hematopoiesis) takes place in the fetal liver and produces long-term 
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hematopoietic stem cells (LT-HSCs) capable of reconstituting the blood system for life, 
shortly before birth and thereafter, the bone marrow becomes the major site of 
hematopoiesis (Shivdasani et al., 1995). In mouse, the first hematopoietic site was 
identified in the extra-embryonic yolk sac (Haar and Ackerman, 1971), termed as blood 
island; whereas similar extra-embryonic blood island counterparts were also found in 
bird and frog (Zon, 1995). For a long time, the extra-embryonic yolk sac was considered 
as the only initiation site of hematopoiesis (Moore and Metcalf, 1970). However, recent 
experiments from amphibians (Turpen et al., 1981; Kau and Turpen, 1983) and birds 
(Martin et al., 1978) demonstrated that the yolk sac is not the only site for the 
hematopoiesis commencement. During avian development, intra-embryonic 
hematopoietic cells appeared in the dorsal mesentery, in para-aortic foci, in the anterior 
region of the mesonephros in association with the postcardinal veins, or in the dorsal 
aorta (Dieterlen-Lievre and Martin, 1981; Cormier and Dieterlen-Lievre, 1988). Stem 
cells from this intra-embryonic region differentiate into the definitive erythrocyte 
population and also give rise to progenitors that colonize the thymus and bursa of 
Fabricious (Lassila et al., 1978; Lassila et al., 1982). The analogous compartment in the 
Xenopus embryo is the mesoderm of the dorsal lateral plate (DLP), which contributes to 
definitive erythroid and lymphoid populations (Turpen and Knudson, 1982). The 
corresponding intra-embryonic region termed either aorta-gonads-mesonephros (AGM) 
or para-aortic splanchnopleura (P-sp) in mouse were found to contain cells with the 
capability of long-term reconstitution of the hematopoietic system when injected into 
irradiated mice (Godin et al., 1993; Medvinsky et al., 1993), also supporting the 
presence of second hematopoietic initiation site in the intra-embryonic region. Thus, the 
ontogeny of hematopoiesis is initiated independently from two different anatomical 
locations during embryogenesis. 
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1.1.3 Hemangioblast Cell 
The presence of two sites for early hematopoietic generation has led to much 
speculation concerning lineage relationships. The concurrent emergence of 
hematopoietic cells and vascular endothelium cells with the similar spatial gene 
expression patterns suggest the existence of a common progenitor, or hemangioblast 
(Dieterlen-Lievre, 1975). Mice with null VEGF receptor Flk-1 or TGFβ1 display the 
deficiency in generation or organization of both blood and vascular cells (Shalaby et al., 
1995; Dickson et al., 1995), indicating interdependence between vasculogenesis and 
hematopoiesis. In the in vitro ES cell (embryonic stem cell) differentiation experiments, 
blast colony-forming cell (BL-CFC) was identified as presumptive hemangioblast cell that 
has the bipotential for hematopoietic and endothelial cell development (Kennedy et al., 
1997; Choi et al., 1998). In addition, the zebrafish cloche mutant exhibits defects on both 
hematopoietic and endothelial lineage cells (Stainier et al., 1995), consistent with the 
requirement of a common progenitor cell. Recent study from embryo-derived blast 
colony found that the potential hemangioblast are first detected at the mid-streak stage 
of gastrulation, with a narrow developmental window spanning approximately 12-18h of 
mouse gestation, dramatically declining at the head fold stage (Huber et al., 2004). 
Although these experiments provide circumstantial evidence to highlight the inseparable 
relationship between hematopoietic cells and vascular endothelium cells and support the 
hypothesis of hemangioblast, isolation of these cells has not been successful.  
1.1.4 Hematopoietic Stem Cell 
The hematopoietic stem cells are the central kernels of the blood cell development. 
Featured with self-renewal and lineage commitment, the HSCs are the forefront of both 
basic stem cell research and clinical applications (Akashi et al., 2000). The bone marrow 
transplantation and peripheral blood stem cell transplantation have been widely used in 
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therapy of immune system deficient patients and for the recovery of the stem cells that 
have been destroyed by high doses of chemotherapy and/or radiation therapy. Although 
the clinical application reveals the powerful multipotenty of HSCs, the ontogeny of these 
cells is still a controversial issue. The cell transplantation experiments demonstrate that 
both yolk sac blood island and AGM have HSCs (Moore and Metcalf, 1970; Medvinsky 
et al., 1993). The yolk sac supports the generation of primitive HSCs and is the first 
homing site for definitive erythroid cell development (Palis and Yoder, 2001). However, 
the yolk sac HSCs can only reconstitute hematopoiesis after the injection to neonatal 
mice but not to irradiated adult host (Yoder et al., 1997). Whereas, the AGM contains the 
definitive HSCs, which possess the ability to reconstitute the hematopoiesis of lethally 
irradiated adult mice (Medvinsky and Dzierzak, 1996). The relationship between these 
two populations of HSCs is largely unknown (Keller et al., 1999; Yoder, 2001; Cumano 
and Godin, 2001). Some studies suggest independent origins of primitive and definitive 
HSCs(Dieterlen-Lievre, 1975; Medvinsky and Dzierzak, 1996), whereas others provide 
evidence for a common precursor population, which arises in the yolk sac to provide 
primitive hematopoiesis for the early embryo but also seeds the AGM and fetal liver as 
these sites become competent to support HSCs and hematopoietic cell development 
(Moore and Owen, 1967; Johnson and Moore, 1975). Recently, the discovery of 
placenta as an important site for HSCs development makes the parentage of HSCs 
more complex (Alvarez-Silva et al., 2003; Gekas et al., 2005; Ottersbach and Dzierzak, 
2005). Nevertheless, the studies of HSCs commencement help us to define the suitable 
microenvironment for HSCs development and may provide information for in vitro culture 
of HSCs in HSCs based-therapy.  
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1.1.5 Hematopoietic Lineage Differentiation 
The hematopoietic lineage differentiation is depicted in a hierarchical fashion, with HSCs 
producing first to progenitors and then to precursors with varying commitments to 
multiple or single pathways. After a transient harboring in the yolk sac and AGM, HSCs 
migrate to the secondary sites of hematopoiesis: the liver, spleen, thymus and bone 
marrow, where the totipotent HSCs give rise to transit populations with restricted 
differentiation capacity (Dzierzak et al., 1998; Delassus and Cumano, 1996). These 
transit progenitor cells, which can be identified by expression of specific lineage markers 
and bioassays of developmental potential in tissue culture or transplantation, eventually 
differentiate into different hematopoietic lineages, for instance, the common lymphoid 
progenitors (CLP) give rise to B-cells and T-cells (Kondo et al., 1997), whereas the 
common myeloid progenitors (CMP) give rise to monocytes, platelets, granulocytes and 
erythrocytes (Akashi et al., 2000). The developmental potential of these cells is generally 
limited to only one or two of the hematopoietic lineages and these cells progressively 
display the antigenic, biochemical, and morphological characteristic of the mature cells 
of the appropriate lineages and lose their capacity for self-renewal (Kondo et al., 2003).  
1.1.6 Molecular Regulation of Hematopoiesis  
The hematopoiesis program, from ventral mesoderm induction to final lineage cell 
differentiation, is controlled by multiple factors and pathways. Gene-targeting 
approaches have been widely applied to define the functions of these factors in the 
primitive and definitive hematopoiesis. In respective T-lymphoid acute leukemia 
oncoprotein Tal-1/SCL (for stem cell leukemia) (Porcher et al., 1996; Robb et al., 1995; 
Robb et al., 1996; Shivdasani et al., 1995) and LMO2 knockout mice (Yamada et al., 
1998; Warren et al., 1994), the lack of precursor determination or maintenance both in 
yolk-sac and fetal liver is observed and indicate that these two genes play important 
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roles in early development of primitive and definitive hematopoietic progenitors. 
Whereas, in knock-out mice for another two transcription factors AML1/RUNX1 (Castilla 
et al., 1996; Wang et al., 1996) and c-MYB (Mucenski et al., 1991), the yolk sac 
hematopoiesis is normal, but the fetal liver hematopoiesis is blocked as HSC generation 
and proliferation are defective, suggesting the specific functions of RUNX1 and c-MYB in 
definitive hematopoiesis. Although no specific primitive hematopoietic deficient mutant 
has been identified so far, studies from these knock-out mice indicate that the 
requirements for primitive and definitive hematopoiesis are distinct. Similarly, the 
erythroid cell deficient in GATA1 knock-out mice (Pevny et al., 1991) and the absence of 
lymphoid cells in Ikaros knock-out mice (Georgopoulos et al., 1994; Nichogiannopoulou 
et al., 1999) demonstrated that GATA1 and Ikaros are key regulators in erythropoiesis 
and lymphopoiesis respectively.   
Although a small number of “master” genes that control the development of different 
hematopoietic cells have been identified, recent studies from microarray analyses reveal 
that lineage differences extend to quantitative changes in the relative level of expression 
of most genes rather than absolute changes in the expression of a limited number of 
lineage-specific genes (Ivanova et al., 2002; Terskikh et al., 2003; Lambert et al., 2003; 
Bruno et al., 2004; Evans et al., 2004). Hence, the combination of biological experiments 
and math arithmetic can efficiently construct a molecular network of hematopoiesis, from 
which the transcriptional regulation mechanisms in different lineage specification can be 
elucidated fairly.  
1.2 Zebrafish as a Good Model Organism 
For centuries, powerful model organisms, such as nematode and fruit fly, have helped 
us to discover many biological and developmental events in cell-fate decisions, pattern 
formation and genetic pathways. However, there are still many remaining questions with 
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regard to chordate development could not be simply answered by these invertebrate 
animals. In recent years, the zebrafish (Danio rerio) has emerged as a new genetic 
model organism to help us decipher the miracles of life.  
1.2.1 Advantages of Zebrafish 
The zebrafish is a small vertebrate that is easy to raise and breed in the laboratory. 
Although about 30 years ago, the legendary zoologist, Curt Kosswig, proclaimed that 
“smaller fish species provide by far the best material, at least among the vertebrates, for 
studying inheritance” (Kosswig, 1973), it was until recently that this small animal became 
the adored “pet” for developmental and genetic research. Comparing to other vertebrate 
organisms, zebrafish has many features that can be easily exploited in the laboratory. 
Firstly, natural weekly mating generate large and synchronous batches of embryos that 
are fertilized externally, allowing them to be easily collected and analyzed with assays 
used in mutagenesis screens. Secondly, its embryonic development is spectacularly fast: 
it generates a typical vertebrate body plan, with a neural tube, muscles, a vascular 
system, and a beating heart, within 24 hours of fertilization. During this process, tissue 
formation and organogenesis can be visualized through the transparent fish body under 
the light microscope. Finally, the small size and the short time required for its sexual 
maturation (3-4 months) permit the large numbers of animals to be maintained in 
relatively small facilities. All these advantages make zebrafish a suitable model organism 
for genetic screening. 
1.2.2 Genetic Screening 
Genetic screening has long been a staple for identification of new genes that regulate 
embryogenesis and adult organ functions. Mutant analyses of model systems, such as 
Drosophila and Caenorhabditis elegnas, have helped us identify many key molecules in 
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different genetic pathways. However, these invertebrate model systems cannot be 
utilized to address the development and function of vertebrate-specific features such as 
kidney, multi-chambered heart, multi-lineage hematopoiesis, notochord and neural crest 
cells. Hence, zebrafish, as a vertebrate genetic model system, have born the important 
task of elucidating the vertebrate development. 
1.2.2.1 Large-Scale Genetic Screening 
In 1993, Nusslein-Volhard, the pioneer of modern genetic study of fly and zebrafish, 
planned to recapitulate the Drosophila screen using chemical mutagen N-ethyl-N-
nitrosourea (ENU) for embryonic pattern mutations in a vertebrate at the Max Planck 
Institute in Tubingen, Germany (Haffter et al., 1996). At the same time, Mark Fishman 
established a parallel effort in Massachusetts General Hospital, USA (Driever et al., 
1996). After 2 years of screening, ~2000 embryonic lethal mutant phenotypes were 
recovered between Tubingen and Boston. Along with the construction of zebrafish 
genome database and genetic linkage maps with the high-resolution of markers by the 
Sanger Center (UK) and National Institute of Health (USA), through positional and 
candidate cloning strategies, the cloning of these zebrafish mutant corresponding genes 
would be feasible and fast. In addition to chemical mutagenesis approach, insertional 
mutagenesis screens using a retroviral system have also been carried out by Nancy 
Hopkins (Amsterdam et al., 1999). More than 300 stable insertion lines have been 
isolated from this approach and most of their corresponsive genes are orthologs of those 
known to be critical in Drosophila, mouse or human development. Although the 
efficiency of retroviral-based insertional mutagenesis is relatively low compared to that of 
ENU mutagenesis, disrupted gene sequences could be easily and rapidly cloned by 
inverse-polymerase chain reaction (PCR) based sequencing, thus providing a new 
powerful screening method in zebrafish. 
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1.2.2.2 Specific “Target” Screening 
The morphology-based screening can identify numerous mutants with defects during 
embryogenesis, whereas detailed developmental processes sometimes cannot be 
visualized just by eye. Hence, “target” screens have been created to dissect the 
particular developmental program or specific organogenesis. Examples are whole mount 
in situ hybridization (WISH)-based genetic screening have been conducted by us and 
others to isolate mutants in T-cell development and thymus organogenesis (Trede et al., 
2001); mutants with non-morphology defects of the digestive organ were identified using 
a fluorescent reporter to visualize enzymatic activity in live embryos (Farber et al., 2001); 
and recently, through behavior screening that monitor behavior in response to a visual 
stimulus, Neuhauss et al. uncovered mutants with genetic disorder of vision (Neuhauss 
et al., 1999; Baier, 2000). Thus, by using these creative designs of genetic screening, 
we can understand particular aspects of vertebrate development in more depth.  
1.2.2.3 Mutants as Human Disease Model 
With elegant experimental designs and incessant endeavors, mutagenesis screens allow 
us to identify plenty of molecules involved in various developmental pathways. These 
mutants provide researchers with an array of resources to analyze different aspects of 
vertebrate embryonic development, and some also resembled human disease states, 
and thus served as a useful tool for investigating the corresponding pathophysiology. Till 
now, many zebrafish models for human diseases have been established, encompassing 
different disorders involved in many tissue and organ development, including 
hematopoiesis, cardiovascular genesis and kidney (Dooley and Zon, 2000). Recently, 
the generation of zebrafish p53 mutants also provides a unique platform to elucidate the 
genetic pathway in tumorigenesis (Berghmans et al., 2005). Hence, through the studies 
in mutants, the mechanisms of many biological events could be uncovered, and their 
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potential on clinical research may help us to find drugs or new therapy methods to treat 
these disorders in human. 
1.2.3 Molecular Techniques 
Along with the generation of mutants, subsequent positional cloning of the genes 
responsible for the phenotypes are just the first steps to identify the molecules that are 
involved in the developmental processes. Molecular techniques are essential for in-
depth studies to elucidate the mechanisms behind these processes. As more and more 
developmental biologists switch their interests to zebrafish, many well-established 
techniques are adopted to this animal and some new approaches specifically for 
zebrafish have also been developed. All these advancement on technology allow the 
study of this model to be more comprehensive. 
1.2.3.1 Microarray 
Gene expression profiling is one of the most useful tools to identify new genes and 
pathways. Microarray techniques have been used for many years to fulfill the gene 
expression analysis. Recently, three different kinds of microarray chips, cDNA chip, oligo 
chip and Affymetrix chip, have been created for the study of zebrafish. Through the 
application of cDNA microarray, Lo et al. compared the gene expression profiles from six 
different embryonic stages and confirmed that the coordination of gene expression is 
important for myogenesis (Lo et al., 2003); whereas, our group and others used 
Affymetrix and oligo arrays to identify many novel hematopoietic and vascular related 
genes by comparing gene expression between wildtype and cloche, a hematopoietic 
deficient mutant (Qian et al., 2005; Sumanas et al., 2005; Weber et al., 2005). More 
fascinatingly, Weinholds et al identified tissue specific expressed microRNAs (miRNAs) 
by using microarray and inferred their functions in tissue differentiation and maintenance 
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(Wienholds and Plasterk, 2005; Wienholds et al., 2005). All these examples illustrate 
that microarray technology is a powerful tool to find new genes, to build up gene 
expression profile database, and in turn to delineate the molecular events in vertebrate 
development.  
1.2.3.2 Morpholino “Knock-down”  
As more and more novel genes are identified through microarray and genomic analyses, 
their roles in development remain obscure. Gene-targeting technology has been well 
established in mouse to study the functions of genes of interest. However, in zebrafish, 
such approach is not available due to the limitations in embryonic stem (ES) cell culture 
(Ma et al., 2001). Fortunately, targeted gene ‘knockdown’ strategy with antisense 
morpholino (MO) has provided an effective and specific way to transiently interfere with 
RNA processing or inhibit translation of individual genes in zebrafish. MOs are 
chemically modified antisense oligonucleotides that are stable in vivo and have base-
stacking abilities similar to those of native RNA molecules (Summerton and Weller, 1997; 
Heasman, 2002). Since MO effects can last up to 10 days, the functions of the genes in 
early development can be evaluated through knockdown experiments (Nasevicius and 
Ekker, 2000). Furthermore, the synergetic or counteractive effects of different genes can 
be easily investigated by co-injecting two or more corresponsive MOs into a single 
embryo. Hence, the combination of using gene transcript microarrays to identify 
candidates and producing antisense molecules in zebrafish for functional screening of 
these candidates is a quick way to identify genes with central roles in vertebrate 
development. This strategy was neatly applied by Catherine Verfaillie and colleagues 
(Eckfeldt et al., 2005), who identified HSCs specific genes using human Affymetrix array 




Although MO knockdown have been widely applied for the functional studies of zebrafish 
genes of interest and proved to be very specific, however, MOs may sometimes 
introduce non-specific phenotypes and conceal the real ones due to toxicity. Hence, in 
addition to this transient method, “targeting-induced local lesions in genes” (TILLING) 
has brought permanent gene inactivation to the zebrafish field (Wienholds et al., 2003). 
Like standard mutagenesis, the adult zebrafish is firstly mutagenized by ENU and served 
as founder fish to generate F1 progeny. In the F1 population, mutations on a specific 
“target” gene of interest can be identified by genomic sequence analysis. Through 
TILLING, it is possible to create an allelic series of mutations in a gene of interest to 
facilitate the identification of critical functional regions or to provide information about 
gene function in cases where a null allele is lethal. Using this approach, a series of 15 
rag1 mutations were found ranging from silent, intronic region to premature stop codon 
(Wienholds et al., 2002). A truncated protein produced by the premature stop was shown 
to be incapable to performing V(D)J recombination, suggesting that the C-terminal of the 
rag1 gene is critical for its function. Despite other missense alleles of rag1 mutants have 
not been well characterized, their hypomorphic features may be useful for genetic 
studies such as suppressor/enhancer screens.  
1.2.3.4 Transgenic Fish 
Transgenic approach is another powerful tool for the analysis of gene function during 
development. Microinjection of DNA constructs has been proven to be a reliable means 
of producing transgenic zebrafish. In the zebrafish, tissue-specific promoters driving the 
expression of the fluorescent reporter protein such as GFP (green fluorescence protein) 
or DsRed have been used to observe the dynamic regulation of gene expression in 
specific cell lineages of transparent living embryos. GFP transgene controlled by gata1 
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promoter helped us to monitor the erythroid cell early development (Long et al., 1997), 
and the flk1 promoter driven GFP limned a beautiful frame of zebrafish blood vessels 
(Jin et al., 2005b). As hundreds of embryos can be microinjected within a single day, the 
temporal and spatial patterns of gene expression can be analyzed quite rapidly. 
Identification of regulatory elements on the zebrafish scl promoter demonstrated that 
transgenic fish is a very useful tool to find cis elements in promoter or enhancer study 
(Jin et al., 2005a). Other than cell fate mapping or promoter study, transgenic fish has 
also been used to create human disease models. Kalev-Zylinska et al transiently 
expressed human RUNX1-CBF2T1 transgene (product of the t(8;21) translocation in 
acute myeloid leukemia) in zebrafish embryos, resulting in disruption of normal 
hematopoiesis, aberrant circulation, internal hemorrhages and cellular dysplasia (Kalev-
Zylinska et al., 2002). These phenotypes mimic the human leukemia caused by RUNX1 
deficiency as a result of t(8:21) chromosome translocation. Conditional transgenic fish 
have also been created by using Cre-loxP system recently, in which the expression of 
cre is controlled by a heat shock promoter (Thummel et al., 2005). To avoid the early 
tumorigenesis in the rag2-EGFP-mMyc transgenic fish, Langenau DM et al generated 
the rag2-loxP-dsRED2-loxP-EGFP-mMyc transgenic fish, in which tumor can be induced 
only at the presence of Cre expression (Langenau et al., 2005). Hence, transgenic fish 
has emerged as one of the most important tools for developmental biology study. 
1.2.4 Genomics and Zebrafish Community 
Zebrafish has 25 chromosomes and its genome consists of approximately 15 billion 
base-pairs, compared to mammalian genome sizes of approximately 30 billion base-
pairs. Although it is currently unknown how many genes there are in the zebrafish, 
based on the gene prediction program, the total number of zebrafish genes will be very 
close to the one expected for mammalian genomes. With the high homology between 
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zebrafish and human and mouse genes, studies from zebrafish provide a powerful 
means to elucidate the complexities of higher vertebrates’ development. 
1.2.4.1 Gene Duplication 
During evolution, like many other fishes, the zebrafish undertook the genome duplication 
or large-scale gene duplication, which is commonly given as the explanation for the 
increase in complexity via the acquisition of new functions (Lynch and Conery, 2000). 
The best evidence for this duplication event is from the studies on Hox genes. The 
function of Hox genes is to specify cell fate in the anterior-posterior axis of animal 
embryos. Invertebrate chordates have one Hox cluster, but mammals have four, 
whereas, the discovery of seven Hox gene clusters in zebrafish (Amores et al., 1998), 
almost twice as many as human and mouse, suggests that genome duplication occurred 
just before the teleost radiation.  
Although the gene duplication makes the analysis of zebrafish genes function more 
complicated, the diverse functions of one single gene that has multiple activities in 
mammals can be easily dissected. One example is the Flk1 gene, which plays an 
important role in the development of hematopoietic stem cells and vascular endothelium 
cells in mammal (Shalaby et al., 1995). An initial report of zebrafish flk1 mutant showed 
that the flk1 gene is essential for angiogenesis, but not for angioblast cell specification in 
zebrafish, suggesting differences in function compared to mammalian Flk1 (Habeck et 
al., 2002). However, recent work has shown that there is a second zebrafish ortholog of 
flk1 and introduction of the morpholino of this gene in the flk1 mutant leads to a more 
complete loss of angioblasts analogous to the phenotype of Flk1-knockout mice 
(unpublished data, Schulte-Merker,S.). These two clusters of flk1 gene allow us to define 
its miscellaneous functions in vasculorgenesis and angiogenesis, and also indicate that 
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the gene duplication of zebrafish genome is one of the unique features to help us define 
genes functions more scrupulously.   
1.2.4.2 Genomic Database 
As genomic information is very important for genetic mapping of mutants, the National 
Insititutes of Health (NIH) launched the Trans-NIH Zebrafish Initiative to map the 
zebrafish genome and develop other genomic tools 
(http://www.ncbi.nlm.nih.gov/genome/guide/zebrafish/index.html). Subsequently, the 
Wellcome Trust Sanger Institute initiated the zebrafish genome-sequencing project. With 
these continuous endeavors, to date, about 60% of the zebrafish genome has been fully 
sequenced. Combined with expeditious increment of expression sequence tags (ESTs) 
and full-length clones, these genome sequence information are assembled and a very 
comprehensive zebrafish genomic infrastructure in Ensembl 
(http://www.ensembl.org/Danio_rerio/index.html) is built (Ashurst et al., 2005). Recently, 
this sequencing project is expanded to Zebrafish Models for Human Development and 
Disease (ZF-MODELS) project (Bradbury, 2004), whose aim is to combine the 
advantages of the zebrafish in developmental biology with recent advances in functional 
genomics and with the zebrafish genome sequence to harvest large data sets on gene 
functions. This project provides us invaluable knowledge and avant-garde technology to 
create disease models, to explore the pathways of gene regulation and also to discover 
drug targets applicable to human diseases. All the information, including genomic 
sequences, mutants and newly developed expression pattern database, can be 
accessed from the online zebrafish information center, http://zfin.org (Sprague et al., 
2001). The website provides not only the prolific information about zebrafish but also 
serves as a unique platform to share and exchange experiences among researchers in 
the zebrafish community.    
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1.3 Hematopoietic Study in Zebrafish  
The zebrafish offers a unique opportunity to discover and study novel genes required for 
the control of normal vertebrate hematopoiesis. This lower vertebrate is a more 
accessible model than the higher organisms as blood formation is established within 24 
hr and circulating blood cells can be visualized under the light microscope. In addition, 
unlike the early lethal phenotypes of most blood deficient mutants in mouse, the 
bloodless mutants in zebrafish can survive for more than 7 days and develop quite 
normally in other non-hematopoietic tissues, providing good exemplars to specifically 
study the blood formation during early vertebrate development.  
1.3.1 Hematopoiesis Program in Zebrafish 
The hematopoiesis program is highly conserved during evolution. In zebrafish, this blood 
formation process can produce all kinds of blood cells, including the cells of the erythroid, 
thrombocytic, myeloid, and lymphoid lineages (Figure 1.1). Like other vertebrate models, 
the zebrafish also have two waves of hematopoiesis, the primitive and definitive 
hematopoiesis, which contribute to the embryonic blood cells formation and adult blood 
cells formation. In addition, the orthologues of the most critical mammalian 
hematopoietic transcription factor genes have been identified in zebrafish (Figure 1.2). 
Given the extensive similarities in hematopoiesis between zebrafish and mammals, an 
understanding of blood cell development from zebrafish provides insights into the 
ontogeny of hematopoiesis program in the higher vertebrates. 
1.3.1.1 Primitive Hematopoiesis in Zebrafish 
As we have discussed in section 1.1.2, the primitive hematopoiesis occurs in the extra-
embryonic yolk sac in mammals and birds. In contrast, the primitive hematopoiesis in 








Figure 1.1 Comparison of Human and Zebrafish Mature Peripheral Blood Cells 









Figure 1.2 Hematopoietic Program in Zebrafish. (Adopted from Hsia and Zon, 2005)   
ALM: anterior lateral mesoderm; PLM: posterior lateral mesoderm; AGM: aorta-gonads-
mesonephros; ICM: intermediate cell mass. 
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located in the trunk ventral to the notochord, and the rostral blood island (RBI) arising 
from the cephalic mesoderm. The origin of the ICM cells is the bilateral stripes of cells in 
the posterior mesoderm. At around 18 hours post fertilization (hpf), these mesoderm 
derived cells migrate to the trunk midline and differentiate into “primitive” 
proerythroblasts and endothelial cells of the trunk vasculature. Concurrently, the 
embryonic myeloid cells appear in the second anatomical site of primitive hematopoiesis, 
the RBI region (de Jong and Zon, 2005).  
Many orthologues of the transcription factors that are involved in mammalian 
hematopoiesis are found in zebrafish. Gene expression analyses indicate that their 
temporal and spatial expression patterns are comparable to their mammalian 
counterparts. In zebrafish, the stem cell leukemia (scl) gene has been demonstrated to 
be a vital factor for the formation of HSCs and angioblasts (Dooley et al., 2005; 
Patterson et al., 2005). At 2-somite stage, the first primitive hematopoietic progenitors 
are marked as bilateral stripes with scl expression in the posterior mesoderm. At the 
same time, these cells also co-express lmo2, gata2 and fli1a, supporting the fact that 
these factors form a multimeric complex and regulate the blood and vascular formation 
in an interactive way (Valge-Archer et al., 1994; Wadman et al., 1997). The presence of 
this complex in RBI at 3~5-somite stage suggests the idea that the common spatial and 
temporal characteristics of blood and vascular development are features shared by both 
rostral (RBI) and caudal (ICM) sites of hematopoiesis. One interesting question is 
whether these early scl+ cells are hemangioblast cells or they are heterogenic cells 
comprising both HSCs and angioblasts. Although many factors are co-expressed in 
these cells, the answer for this question is still controversial. 
At about 4-somite stage, a subset of scl+ cells express erythroid-specific transcription 
factor gata1(Detrich, III et al., 1995). These first committed erythroid cells differentiate 
sequentially in a rostral to caudal direction. The number of these gata1+ erythroid 
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precursors increases as they migrate towards the midline. By the time blood circulation 
begins between 25-26 hpf, the ICM is comprised of at least 300 proerythroblasts (Long 
et al., 1997) that express genes required for red blood cell function and membrane 
stability, such as embryonic globin genes, urod and band3 etc (Wang et al., 1998; 
Brownlie et al., 2003; Paw et al., 2003). Over the next 4 days, the circulating 
proerythroblasts synchronously mature into flattened elliptical erythrocytes, but they are 
clearly distinguishable from adult zebrafish erythrocytes that have a characteristic large 
elongated nucleus and smaller amount of cytoplasm. The first cluster of ICM-derived 
blood cells persists as the only circulating cells for at least 4 days. This result is 
demonstrated by transfusion of fluorescently labeled blood cells from 36hpf donor 
embryos into the sinus venosus of the recipient embryos (Weinstein et al., 1996). The 
proportion of blood cells in the circulation which are contributed by the donor does not 
decline significantly until approximately 6dpf. After 5dpf, both the proportion and number 
of donor blood cells decline gradually, reaching approximately 50% of their starting 
values by 10 dpf. At 10 days, labeled transfused erythrocytes are noticeably smaller in 
size than many unlabelled erythrocytes, indicating the emergence of a morphologically 
distinctive new erythrocyte cell population. These results indicate that primitive 
erythrocytes are a single population of blood cells originating from the ICM, which are 
formed and matured during the first 5 days of development in zebrafish embryos. 
The first macrophages are identified in the lateral mesoderm of the head at the 3-somite 
stage (Herbomel et al., 1999; Bennett et al., 2001; Lieschke et al., 2002). Like erythroid 
cell differentiation in the ICM, the development of myeloid cell in the RBI is also marked 
by some myeloid-specific factors. At 11~15-somite stage, a subset of these anterior cells 
expresses pu.1, a member of the ETS family of transcription factors essential to the 
development of myeloid cells (Lieschke et al., 2002). This subset of pu.1+ cells 
represents the early myeloid cells, including macrophages and granulocytes, which 
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migrate rostrally and then laterally across the yolk sac around 22-24 hpf. Although pu.1 
expression levels in these macrophage precursors decline after the 18-somite stage, 
additional molecular markers including c/ebp1, fms, l-plastin, and lysozyme-c are 
expressed at this time (Herbomel et al., 1999; Bennett et al., 2001; Lyons et al., 2001; 
Herbomel et al., 2001; Liu and Wen, 2002; Lieschke et al., 2002). These early 
macrophages has been observed to be in action as early as 26 hpf in the ducts of Cuvier, 
where macrophages can be seen ‘interrogating’ and engulfing apoptotic erythroblasts 
from bloodstream (Herbomel et al., 1999). These macrophages express l-plastin and are 
distributed throughout the embryo by 28-32 hpf. Primitive immune function of 
macrophages is also evident as they migrate to the site of an infection with Escherichia 
coli or Bacillus subtilis and phagocytose the offending organisms, and they can clear 
microinjected carbon particles from the circulation as early as 2 dpf (Herbomel et al., 
1999; Lieschke et al., 2001). Another population of RBI-derived myeloid cell is the 
granulocyte. The expression of the granulocyte-specific marker myeloperoxidase 
(mpo/mpx; encoding an enzyme abundant in the granules of mature neutrophils and 
eosinophils) is first detected at 18 hpf in presumptive neutrophilic precursors within the 
caudal ICM and co-localized with some pu.1+ myeloid progenitors (Bennett et al., 2001). 
Soon after this stage, mpo+ cells also appear scattered on the anterior yolk sac. 
Although very few mpo-expressing cells co-localize with l-plasin, consistent with these 
two populations representing distinct granulocyte and macrophage lineages, both of 
these two markers are also expressed in the caudal ICM region, indicating that the ICM 
also gives rise to a small population of myeloid progenitors. 
1.3.1.2 Definitive Hematopoiesis in Zebrafish 
The definitive HSCs in mammals are first identified in the intra-embryonic AGM region. 
In zebrafish, the AGM counterpart is also found in the ventral wall of the dorsal aorta, 
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where definitive HSCs marker gene runx1 is expressed between 24~48 hpf (Kataoka et 
al., 2000; Burns et al., 2002; Kalev-Zylinska et al., 2002). The expression of other 
transcription factors including c-myb, ikaros, lmo2, and scl also support the hypothesis 
that these AGM-derived cells are definitive HSCs (Thompson et al., 1998). Around 4~5 
dpf, the location of blood formation shifts to the kidney where the lifelong definitive 
hematopoiesis is established (Willett et al., 1999; Galloway and Zon, 2003). In the adult 
zebrafish, hematopoietic cells are found intercalated between the renal tubules in the 
kidney marrow, much like mammalian adult hematopoiesis that takes place in and 
around the fat and stroma of the bone marrow. Like mammals, the zebrafish definitive 
hematopoiesis also gives rise to all the erythroid, thrombocytic, myeloid, and lymphoid 
lineages (Traver et al., 2003b).  
The definitive erythropoiesis is postulated to begin around 5dpf, as the recovery of 
circulating red blood cells in primitive erythropoiesis deficient mutant bloodless is around 
this stage (Liao et al., 2002). Like other higher vertebrates, globin switching from 
primitive embryonic globin chains to the adult globin chains is the hallmark of definitive 
red blood cell formation (Chan et al., 1997; Brownlie et al., 2003). The zebrafish 
thrombocytes are nucleated blood cells equivalent to mammalian platelets, which 
function to maintain hemostasis by facilitating clot formation (Jagadeeswaran et al., 
1999). Although the ontogeny of these thrombocytes is not well understood, the 
adhesion and aggregation of these cells in response to ristocetin, collagen, thrombin, 
ADP, and arachidonic acid suggest that they have similar function as mammalian 
platelets (Hill and Rowley, 1996; Jagadeeswaran et al., 1999; Gregory and 
Jagadeeswaran, 2002). At 7dpf, myeloblasts and neutrophilic granulocytes are readily 
observed within the pronephros. At this time, both macrophage marker lysozyme-c and 
granulocyte marker mpo are expressed in these myeloid progenitor cells (Willett et al., 
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1999; Liu and Wen, 2002), however, whether these cells are from primitive myeloid cell 
or they are representation of a second wave of myelopoiesis is still largely unknown. 
The most significant difference between primitive and definitive hematopoiesis is the 
evidence of lympoid lineage cells. In zebrafish embryos, a combination of histological 
and gene expression analyses have identified the thymus, pancreas, and pronephros as 
sites of lymphopoiesis. Like mammals and other vertebrates, zebrafish possess an 
adaptive immune system containing T and B lymphocytes. The T cell maturation takes 
place in the zebrafish thymus, as it does in mice and human. The pharyngeal epithelium 
between the third and fourth pharyngeal pouches outgrowth form the bilateral thymic 
primordial, where the first immature lymphoblasts are populated around 65 hpf (Willett et 
al., 1997a; Willett et al., 1997b; Willett et al., 1999). The origin of the lymphoid 
progenitors that first populate the thymus rudiment is not known. Given the timing when 
these cells appear, their progenitors must not originate in the kidney marrow, because 
HSCs are not found there until 5-6 dpf. In mouse, the T-cell precursors originate from the 
splanchnopleural mesoderm (from which the AGM region is derived), thus, it has been 
proposed that in zebrafish, the lymphoid progenitors that seed the thymus descended 
from AGM-HSCs generated between 24 and 48 hpf. This hypothesis is supported by the 
evidence that ikaros-expressing cells can be detected both in the AGM region as well as 
throughout the pharyngeal arches at 48 hpf (Willett et al., 2001). Relative to T 
lymphopoiesis, B-cell formation initiates later in zebrafish development. The first 
immunoglobulin (Ig) gene rearrangements are detected by polymerase chain reaction 
(PCR) at 4 dpf, whereas transcripts for the membrane form of IgM appear at 7 dpf. 
Whole mount in situ hybridization of rag1 genes shows that the initial site of B 
lymphopoiesis is likely to be the region of the pancreas primordium of 4 dpf larva 
(Danilova and Steiner, 2002). However, lymphocytes labeled with GFP are not detected 
in the pancreas of larval rag2gfp or lckgfp transgenic zebrafish (Langenau et al., 2004). 
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While the reason for this discrepancy is unknown, it is clear that the pronephros 
becomes an active and major site for B lymphopoiesis starting at 19 dpf, consistent with 
its role as the mammalian bone marrow equivalent (Danilova and Steiner, 2002). 
1.3.2 Methods of Studying Hematopoiesis in Zebrafish 
As we have discussed in section 1.2.3, while the forward and reverse genetic methods 
have been widely employed on hematopoiesis study in zebrafish, recent methodological 
advances on cell sorting and transplantation intensively enhance the hematopoiesis 
study in zebrafish. These techniques provide means to evaluate the cell autonomous 
requirement of mutant genes, assay of leukemic transformation, test for HSC activity, 
and to examine cell migration and homing. 
In mouse, cell sorting is the most important advancement for comprehensive 
understanding of the hierarchical development of blood cells. Recently, Traver D. and 
colleagues successfully applied this technique to isolate the major blood lineages from 
whole-kidney marrow (WKM) in zebrafish (Traver et al., 2003b). Using combined profiles 
of forward scatter (FSC, cell size) and side scatter (SSC, cellular granularity), the blood 
cells can be separated into 4 groups: mature erythroid cells, myelomonocytic cells, 
lymphoid cells and immature precursors. Although the lack of specific antibodies for 
different lineages markers in zebrafish prevent further classification of these cells, the 
generation of transgenic fish under gene specific promoters allow us to isolate different 
blood lineage cells in detail. Analysis of WKM isolated from transgenic zebrafish 
expressing enhanced GFP (EGFP) under the control of  gata2 promoter showed that the 
GFP+ cell are predominantly myeloid cells, further morphological analysis revealed that 
the majority of these cells are eosinophils. Similarly, lymphocytes and erythrocytes have 
been isolated from rag2eGFP and gata1eGFP transgenic fishes, respectively. The isolation 
of different lineage cells by cell sorting not only differentiate erythroid, myeloid and 
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lymphoid cells in normal wildtype fish, but also provides cell biology evidence to 
characterize hematopoietic cells in mutants. The blood mutant retisna (ret) has mutation 
in the gene, anion exchanger 1 (slc4a1) (Paw et al., 2003). It presents the phenotype of 
gradual decrease in blood counts throughout the larval stages as a result of failure in 
membrane integrity. Cell sorting on heterozygous ret mutants displayed mild anaemia 
with a concomitant twofold increase in the precursor scatter population. Further sorting 
of the precursor fraction showed predominance of immature erythroid cells. This 
observation indicates the erythrocytes require a full dosage of slc4a1 for normal 
development. Cell sorting also provides the opportunity to generate lineage specific 
cDNA libraries, when combined with microarray technology, can define the molecular 
signatures of different hematopoietic cells (Traver et al., 2003a).  
With the establishment of cell sorting techniques, the hematopoietic cell transplantation, 
an important clinical and research approach used in other vertebrate hematopoietic 
studies, has also been developed in zebrafish. In the embryos of zebrafish gata1 mutant 
vlad tepes, transplantation of wild-type kidney marrow cells (carrying a gata1gfp 
transgenic reporter) is sufficient to rescue a small fraction of mutants for at least 8 
months (Traver et al., 2003b). To assess the distribution of HSCs in WKM, Traver et al 
transplanted the lymphoid, erythroid, precursor and myeloid fraction of WKM in gata1eGFP 
transgenic fish into wildtype 48hpf embryos and revealed that only the lymphoid fraction 
contains long-term reconstituting HSCs and is capable of long-term EGFP+ erythrocyte 
generation within 6 months time after transplantation. In addition, Langenau et al 
recently discovered the homing properties of zebrafish lymphocytes using the lckgfp 
transgenic fish (Langenau et al., 2004). Transplantation of lckgfp cells from adult kidney 
marrow into 2dpf embryos allowed the visualization of T-cell homing to the thymus by 3 
days of age, indicating the embryonic thymus expresses receptors or chemoattractants 
that facilitate the migration of mature T cells to the thymus. Hence, the combination of 
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cell sorting and transplantation provide a useful tool to dissect the developmental 
processes of different hematopoietic lineage cells and their functions in the normal 
hematopoiesis as well as in the diseased condition. 
1.3.3 Hematopoietic Mutants and Disease Model  
Genetic screenings in zebrafish have generated many mutants with hematopoietic 
defects. To date, more than 40 mutants, consisting of 26 complementation groups, are 
identified in the large-scale chemical mutagenesis screenings in Boston and Tubingen 
(Weinstein et al., 1996; Ransom et al., 1996). These mutants were initially identified by 
the absent or decreased blood circulation in early embryos and were later characterized 
by the gene expression analysis of known hematopoietic transcription factors, such as 
gata1 and scl. These mutations fall into three groups: HSCs deficient mutants, early 
erythroid development mutants and late stages erythroid mutants. Many of these 
mutants represent models of human disease. 
1.3.3.1 HSCs Mutants 
There are three mutants in this group: cloche (clo), spadetail (spt), and kugelig (kgg). 
The clo mutant was initially identified because of the enlarged heart and lack of blood 
circulation after 24hpf (Stainier et al., 1995). Further histology and gene expression 
analyses showed that the endocardium and all blood lineage cells are lost in this mutant, 
whereas adjacent tissues formed normally, indicating that the clo defect is specific to the 
hematopoietic and vascular lineages, most likely, the hypothetical hemangioblast cells 
(Liao et al., 1997; Thompson et al., 1998; Liao et al., 1998). As the clo gene is located at 
the telomere, the positional cloning of the corresponding gene has not been fulfilled yet. 
The second mutant, spt, is caused by a defect in tbx16, encoding a T-box transcription 
factor (Griffin et al., 1998). In spt, at gastrulation stage, the cells that would normally 
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contribute to the trunk somites accumulated in the tailbud instead, indicating the tbx16 
gene is involved in regulating proper cell migration during gastrulation. Although the RBI-
derived myeloid cells and pronephric duct precursors are relatively normal, the absence 
of erythroid cells suggested defects in ICM-HSCs in spt mutants (Thompson et al., 1998; 
Oates et al., 1999). The kgg mutant was first characterized by a shortened tail and 
reduced yolk tube extension (Haffter et al., 1996; Hammerschmidt et al., 1996). Similar 
to spt mutant, the kgg embryos are severely anaemic and hematopoietic defects are 
also seen in the ICM-derived erythroid cells but not in RBI-derived myeloid cells. 
Through positional cloning, the corresponsive gene for kgg is cdx4, which belongs to the 
caudal-related homeobox transcription factor family (Davidson et al., 2003). In 
vertebrates such as mouse, frog and chick, members of the cdx family have been 
implicated in AP patterning of the embryonic body axis by acting as ‘master regulators’ 
of the Hox genes, another family of homeobox transcription factors (Lohnes, 2003). In 
the kgg mutant, hox genes expressed in the anterior trunk exhibit expanded expression 
domains towards the posterior, while more caudally expressed hox genes are reduced 
or absent expression. Concomitant with these perturbations in hox expression domains, 
there is a severe reduction in ICM-HSCs but not in the adjacent angioblasts population. 
These observations suggest an additional and more specific requirement for hox genes 
in the specification of ICM-HSC fate (Davidson et al., 2003). 
1.3.3.2 Early Bloodless Mutants 
Mutants in this group include vlad tepes (vlt), moonshine (mon) and bloodless (bls), 
which possess defects in the development of erythroid progenitor cells. Mutation in vlt 
corresponds to the well-known erythroid-specific transcription factor gata1 (Lyons et al., 
2002). Like gata1 knockout mouse (Pevny et al., 1991), vlt retains normal hematopoietic 
progenitors, myeloid cells and lymphoid cells. However, the lack of functional gata1 
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makes the hematopoietic progenitors unable to differentiate down to the erythroid 
lineage. This phenotype strongly suggests that the gata1 gene is specifically involved in 
both primitive and definitive erythroid cell differentiation. Mutations in the mon mutant 
cause a disruption in both primitive embryonic and definitive adult hematopoiesis, 
resulting in a severe loss of erythroid cells (Ransom et al., 1996). Although the erythroid 
progenitor cells in mon mutants are initially present, they fail to express normal levels of 
hematopoietic transcription factors and eventually undergo apoptosis. Transplantation 
studies showed that the defects in mon mutants are in a cell-autonomous manner during 
the differentiation of erythroid precursors. Ultimately, positional cloning revealed that the 
mon gene encodes the zebrafish orthologue of the mammalian transcriptional 
intermediary factor 1 γ (TIF1γ) (Ransom et al., 2004). The last mutant bls was originally 
isolated as a spontaneous mutation and was inherited in an autosomal dominant fashion 
with incomplete penetrance (Liao et al., 2002). The mutant embryos have no visible 
circulation until approximately 5 dpf when hemoglobinized cells begin to appear, 
coincident with the onset of definitive hematopoiesis. In bls adult, the kidney marrow 
hematopoiesis appears normal, indicating that only primitive erythropoiesis is affected. 
Cell transplantation experiments showed that cells derived from bls mutant donors can 
differentiate into blood cells in a wild-type host, but wild-type donor cells fail to form 
blood in the mutant host. These observations demonstrate that the bls gene product is 
uniquely required in a non-cell autonomous manner for primitive hematopoiesis. Given 
that bls is the only primitive hematopoietic deficient mutant in the vertebrate, positional 
cloning of bls corresponding gene will provide us indispensable information in the 
understanding of the difference between primitive and definitive hematopoiesis in 
vertebrate development.   
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1.3.3.3 Late Stage Erythrocyte Mutants  
While the above two groups of zebrafish hematopoietic mutant help us to comprehend 
the nature of blood development from the initial HSCs to the final lineage cells, the 
mutants in this group establish some very useful disease models that mimic the human 
anaemia. Based on the different types of human anaemia, these mutants can be 
classified into three categories: hemolytic anaemia, hypochromic anaemia and 
erythropoietin porphyria. The hemolytic anaemia mutants, including cabernet (cab), 
chablis (cha), grenache (gre), merlot (mot), riesling (ris), retsina (ret) and thunderbird 
(tbr), have a phenotype of decreasing number of blood cells after apparently normal 
blood development in the first 2 dpf (Ransom et al., 1996; Weinstein et al., 1996). The 
progressive anaemia phenotype of these mutants suggests that these mutations affect 
the erythroid cell expansion or the stability of mature red cells. Most of the corresponsive 
genes for these mutations have been cloned and their functions are found to be involved 
in the construction of red blood cell framework, such as maintenance of membrane 
structure (mot, cha and ris) (Liao et al., 2000; Shafizadeh et al., 2002) and segregation 
of chromosome (ret) (Paw et al., 2003). These results indicate that the main reason of 
human hemolytic anaemia is instability of red blood cell cytoskeleton. In the second 
category, mutants such as chardonnay (cdy), chianti (cia), clear blood (clb), frascati (frs), 
sauternes (sau), weissherbst (weh), and zinfandel (zin), are shown to have hypochromic 
microcytic anaemia characterized by a reduced number of primitive erythrocytes, which 
are pale and small in size (Ransom et al., 1996; Weinstein et al., 1996). This phenotype 
indicates that the defect lies in the production of hemoglobin. Genetic identification of 
these mutations revealed that the corresponsive genes for these mutants are involved in 
different processes of hemoglobin production, including regulation of iron metabolism 
(weh, cdy and cia) (Donovan et al., 2000; Donovan et al., 2002; Wingert et al., 2004) and 
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the de novo synthesis of heme and globin (sau and zin) (Brownlie et al., 1998; Brownlie 
et al., 2003). The last category of photosensitive mutants consists of dracula (drc), 
desmodius (dsm), freixenet (frx), and yquem (yqe) (Ransom et al., 1996; Weinstein et al., 
1996). These mutants produce normal numbers of erythrocytes, but the cells 
autofluoresce and lyse when exposed to ambient light. This phenotype is analogous to 
the human congenital erythropoietic porphyries, which is due to defects in heme 
biosynthesis pathway. The genes responsible for mutants yqe and drc have been 
positional cloned as uroporphyrinogen decarboxylase (UROD) (Wang et al., 1998) and 
ferrochelatase (Childs et al., 2000), respectively.  
1.3.3.4 Transgenic Fish As Disease Models 
Other than using mutants as disease models, the transgenic approach can be used to 
simulate some hematopoietic disease, e.g. leukemia. In addition to chromosome 
translocation model in RUNX1-CBF2T1 transgenic zebrafish (section 1.2.3.4), Langenau 
et al. generated a transgenic model of Myc-induced T-cell acute lymphoblastic leukemia 
(T-ALL) (Langenau et al., 2003). The zebrafish rag2 promoter was used to drive 
lymphoid expression of murine c-Myc, an oncogene known to participate in the 
pathogenesis of mammalian lymphoid malignancies. Approximately 5% of the F0 
founder fish developed lymphoblastic leukemia with aggressive infiltrations in the 
intestine, gills, skeletal muscle, and fins within 30-131 days. To further aggrandize the 
study of this disease model, rag2-myc transgene was injected into rag2gpf transgenic 
embryos, and then these fluorescent labeled leukemia cells can help us visualize the 
disease onset and the spread of lymphoblasts from the thymus in living animals. In 
addition, this inducible line of leukemia-prone fish can be used as founder to perform 
“second-hit” screening to find mutations that influence the development of the leukemic 
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phenotypes, as well as to provide a resource for the discovery of compensating 
mutations or chemicals that would prevent leukemia development.  
1.4 Objective of the Study 
We took advantage of zebrafish as a good vertebrate model system to study the early 
development of hematopoiesis. Both genetic and functional genomics approaches have 
been conducted to identify key molecules in this program. Firstly, we carried out forward 
genetic screen using T-cell specific gene rag1 as a marker. Through this in situ based 
screen, we hoped to identify genes involved in T-cell early development and thymus 
organogenesis. Secondly, we used microarray techniques to compare the gene 
expression profiles between wild-type and zebrafish early hematopoietic and vasculature 
deficient mutant cloche. The affected genes identified from microarray analysis could 



















2 Chapter II:  Material and Methods 
 
2.1 Zebrafish 
2.1.1 Fish Maintenance 
Zebrafish (Danio rerio) AB strain obtained from Tubingen was used as wild-type line for 
daily crossing and mutagenesis. Fish were maintained in central fish facility in IMCB 
according to standard methods described by Westerfield (Sprague et al., 2001).The clos5 
allele and flk1 promoter driven EGFP transgenic fish were generously provided by Dr. 
Didier Y. R. Stainier (Jin et al., 2005b). The montg234 was kindly provided by Artemis 
Pharmaceuticals GmbH (Germany). 
2.1.2 Stages of Embryonic Development 
For developmental studies, the accurate staging of the embryos is very important for 
defining the timing of various developmental events. To obtain synchronized embryonic 
stages of zebrafish embryos, male and female fish were separated by a divider in the 
crossing tank the day before crossing day. On the morning of the crossing day, the 
divider was removed to let the male and female fish mate. The fertilized eggs were 
collected in a petri dish containing egg water (0.03% sea salt in distilled water) 15 min 
after the female fish started to spawn and raised at 28.5°C. The desired stages were 
determined under stereomicroscope (LEICA) according to Kimmel’s description (Figure 
2.1, Kimmel et al., 1995). 
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Figure 2.1 Stages of Embryonic Development of the Zebrafish. (Adopted from 
Kimmel et al., 1995) 
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2.1.3 General Manipulation for Zebrafish 
2.1.3.1 Microinjection 
The samples for injections were diluted in nuclease-free water to the desired 
concentration. Equal volume of phenol red (0.1% in DPBS, Sigma) was mixed with the 
injection sample to facilitate monitoring of the injection process. Before 1 cell stage, 0.5-
1nl of each sample was injected into the middle of embryo yolk by using gas 
microinjector (PLI-100, HARVARD APPARATUS). The injected embryos were then 
raised in incubator at 28.5°C. 
2.1.3.2 Whole Embryo Staining for Globin Expression 
o-Dianisidine staining was used to study the expression of hemoglobin (Detrich, III et al., 
1995). Live embryos after 36 hrs post-fertilization (hpf) were dechorionated by pronase 
(0.5mg in 1ml egg water) treatment, followed by a brief wash in phosphate buffered 
saline (PBS, 58mM NaH2PO4, 2.7mM KCl, 10.1mM Na2HPO4, 1.8mM KH2PO4). The 
embryos were then placed in the staining buffer, which contains o-dianisidine (0.6mg/ml), 
0.01M sodium acetate (pH 4.5), 0.65%H2O2, and 40% (v/v) ethanol, in dark for 15 min. 
The o-dianisidine staining was then observed under the light microscope. 
2.1.4 Genetic Screen in Zebrafish 
2.1.4.1 ENU Mutagenesis 
The mutagenesis process was carried out with chemical mutagen ENU according to the 
standard protocol with minor modifications (Mullins et al., 1994; Solnica-Krezel et al., 
1994). Male fish were crossed with females the night before mutagenesis. The male fish 
that gave fertilized offsprings were selected and transferred to a 5-liter container with fish 
water (50% tap water, 50% RO water) at 22°C in the morning. 6 to10 fishes were placed 
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in an 800ml plastic cylinder with fine mesh bottom, and then dunked in 300ml of ENU 
working solution (3mM ENU in 10mM sodium phosphate buffer) at 22.5°C. After one 
hour’s treatment, the fish were transferred to the cylinder with fresh fish water and left for 
6 hr before transferring into a 5-liter container with 28°C fish water for the night. This 
process was repeated 3 times within 1 to 3 weeks. The ENU working solution were 
mixed with equal amount of 2X inactivation solution (20% sodium thiosulfate, 1% NaOH) 
and incubated overnight to inactivate the ENU before discard. 
2.1.4.2 Generation of F1 and F2 Family  
The ENU treated male fish were mated with untreated female fish two days following the 
last mutagenesis treatment. These male fish were unable to produce viable embryos. 
They need to be out-crossed at least twice before they can produce normal embryos 
weekly. These mutagenized males (F0) that were able to produce fertilized embryos 
were selected and out-crossed with wild-type females to generate F1 fish.  Each F0 
male generated about 100 F1 progeny. When the F1 fish matured, siblings were mated 
with each other to raise the F2 families. Each F2 families consisted of at least 40 fish. 
After the generation of F1 fish, the F0 male fish were stored at -70°C to preserve their 
DNA for positional cloning in the future.  
2.1.4.3 rag1 Screen 
The F2 fish matured after about 3-4 months and could be used to set up in-cross for F3 
screening. Ideally, each F2 family should have about 10 successful crosses. On 
Mondays and Thursdays of the week, approximately 200 pairs of fish from different F2 
families were mated. Embryos from successful crosses were collected on the next day 
and the F2 parents were maintained in the system in each individual tank with 
appropriate tracking number. The dead embryos were removed next morning and the 
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egg water was changed to PTU water (0.003% 1-phenyl-2-thiourea in egg water) to 
prevent pigmentation. After 4 days, about 40 surviving embryos from each cross were 
subjected to whole mount in situ hybridization (WISH) using rag1 as a probe in specially 
designed boxes (Figure 2.2A, see section 2.4.2).  A F2 pair was selected as potential 
mutant candidate should about one quarter of the embryos have dramatic decrease or 
negative rag1 signal. Each mutant was re-confirmed by repeating the WISH at least 
twice. 
2.2 General DNA Application 
2.2.1 PCR and Cloning 
To examine the expression pattern of Affymetrix target genes, we generated clones with 
partial sequences of responsive genes based on Affymetrix target sequence. First strand 
cDNA was synthesized from 1μg of 18hpf or 24hpf fish total RNA by using oligo dT as 
primer. The synthesized cDNA template was then diluted 2.5 times with 1X TE (10mM 
Tris.HCl, 1mM EDTA). PCR reactions were performed using 2μl of the diluted cDNA 
template in 25μl reactions containing 200nM of forward and reverse primers (Table 2.1A), 
200μM of each dNTPs, 1X Advantage2™ buffer ,0.5μl  Advantage2™ polymerase 
(Clontech) and sterilized double distilled water (DDW). Thermocycling parameters 
consisted of an initial denature step of 1 min at 94°C followed by 30 or 35 cycles of 94°C 
for 5 sec, 58°C for 10 sec, 72°C for 1 min and a final extension of 10 min at 72°C. The 
PCR products were analyzed on 1% agarose gel (Invitrogen) and subsequently ligated 
into T/A vector pGEM®-T Easy Vector (Promega) or pDrive Cloning Vector (Qiagen). 
After 1 hr fast ligation at room temperature (RT), 2μl of ligation products were incubated 
with 50μl DH5α competent cells for 40 min on ice, followed by a 50-sec heat-shock on 
the 42°C heat block. The heat-shocked competent cells with ligated plasmid were put 









Figure 2.2 Specially Designed Multi-well Boxes for WISH Screening. A: 8X8 in situ 
box for simultaneous detection of multiple samples. B: 4X6 in situ box for simultaneous 
detection of different probes.  
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added to the competent cells to facilitate blue/white selection before spreading the 
bacterial cell onto LB plate containing ampicillin (100μg/ml). After an overnight 
incubation at 37°C, colonies were picked and subjected to colony PCR to further screen 
for the desired clones. White colonies were randomly picked from the plate using the tips 
of toothpicks, followed by stirring each tip in individual reaction mix and then in a PCR 
tube that was labeled correspondingly with 50μl of LB containing ampicillin. The tubes 
with LB were incubated at 37°C for future large culture. Each 20μl colony PCR reaction 
consisted of 2μl 10x buffer, 0.4μl Taq polymerase, 0.4μl M13 Forward and Reverse 
primers (10μM), 0.4μl dNTPs mix (10mM) and 16.4μl DDW. The colony PCR program 
was set up as 10 min 94°C initial denaturation, followed by 35 cycles of 94°C for 10 sec, 
55°C for 15 sec, 72°C for 1 min, and a final extension of 5 min at 72°C. Colonies that 
showed correct predicted size of PCR products on the 1% agarose gel were selected as 
potential accurate clones. The corresponding 50μl LB culture was topped up to 2-3ml LB 
containing ampicillin and cultured at 37°C for plasmid extraction the next day. 
2.2.2 Plasmid DNA Extraction 
To extract small amount of plasmid DNA, single colony was picked from LB plate and 
inoculated in 2-3ml LB medium containing appropriate selective antibiotic. The cultures 
were incubated overnight at 37°C with vigorous shaking. On the next morning, 200μl of 
the overnight culture was mixed up with 200μl of 50% glycerol and stored at -80°C to be 
used as stock for future use. The remaining bacterial culture was spun down at full-
speed for 3 min in a bench-top centrifuge (Eppendorf), The supernatant was discarded 
and the plasmid was extracted from the pellet using Miniprep column kit (Qiagen) 
according to the manufacturer’s protocol. Generally, approximately 20μg of plasmid 
could be recovered from a 2ml culture. Midi or Maxi columns (Qiagen) were used to 
extract larger amount of DNA. 
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2.2.3 DNA Sequencing  
A standard 20μl DNA sequencing reaction contained 8μl BigDye™ (V3.1) (ABI), 1μl 
appropriate primer (10μM), 100-200ng plasmid DNA and DDW. Thermocycling 
parameters for sequencing consisted of an initial denaturation step of 3 min at 95°C 
followed by 35 cycles of 95°C for 30 sec, 52.5°C for 10 sec and 60°C for 4 min. The 
PCR cycled sequencing reactions were sent to the IMCB Central Sequencing Facility for 
clean-up and sequencing analysis.  
2.2.4 DIG DNA Probe Labeling 
PCR method was used to synthesize DIG labeled DNA probe for Northern blotting or 
Virtual Northern blotting analysis. The PCR reaction mixture composing of 0.5μl Taq 
polymerase (Qiagen), 2.5μl 10X PCR buffer, 0.5μl of gene specific forward and reverse 
primers (10mM), 2.5μl PCR DNA DIG Labeling Mix (Roche), 2-5ng plasmid or PCR 
products as template, was topped-up to 25μl with DDW. A normal PCR reaction was set 
up as a control at the same time. After the PCR reaction, 2μl of labeled and control 
products were analyzed on 1% agarose gel and the yield was estimated by comparing to 
the fluorescence density of 1Kb ladder (NEB). 
2.2.5 Virtual Northern Blotting 
To assess the quality of cDNA after PCR amplification, I developed the Virtual Northern 
blotting based on the principles of Southern blotting method (Joseph Sambrook, 2001). 
Firstly, 5μl of amplified cDNAs were run on a 1% agarose gel along with 50ng of 1Kb 
ladder on a separated lane. After 1-2 hr of electrophoresis, the gel was first examined 
under UV light and treated for blotting with brief rinse between each step: 10 min in 
depurination solution (250mM HCl); 15 min in denaturation solution (0.5M NaOH, 1.5M 
NaCl); 15 min in neutralization solution (0.5M Tris-HCl, 1.5M NaCl, pH adjusted to 7.5). 
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After a brief rinse in DDW, the cDNAs on the gel were transferred onto a nylon 
membrane (Hybond N+, Amersham Bioscience) by the vacuum blotter (Bio-Rad) with 
6XSSC (0.9M NaCl and 0.09M Sodium Citrate, pH adjusted to 7.0). After 2 hr of transfer, 
the membrane was placed face up on a plastic sheet and auto-crosslinked twice in a UV 
crosslinker (Stratagene). The membrane was pre-hybridized with DIG-Easy Hyb buffer 
(Roche) for at least 1 hr at 42°C. 100-200ng DIG labeled probe was diluted in 5ml DIG-
Easy Hyb buffer and incubated with the membrane overnight at 42°C. On the following 
morning, the probe was carefully removed and stored at -20°C for reuse. The membrane 
was rinsed with 2XSSC and followed by a series of washing with vigorous shaking: 
primary washing buffer (2XSSC, 0.1%SDS) for 2x15 min at RT; secondary washing 
buffer (0.2XSSC, 0.1%SDS) for 2x15 min at 50°C; washing buffer (0.1M Maleic Acid, 
0.15M NaCl and 0.3% Tween20, pH adjusted to 7.5) for 5 min at RT. After all the 
washes, the membrane was submerged in Blocking Solution (Roche) for at least 45 min 
at RT with gentle shaking, followed by incubation with anti-DIG-AP Ab (1:10000 dilution 
in Blocking Solution) for 30 min at RT. The membrane was then rinsed with washing 
buffer for 15 min at RT, and subsequently equilibrated with detection buffer for 3 min. 
Chemiluminenscent substrate, Ready-to-use CDP-Star (Roche), was applied drop-wise 
over the surface of the blot until the entire surface was evenly soaked and incubated for 
5 min at RT. Excess substrate was removed and the membrane was exposed to an X-
ray film at RT for 5 min to a few hrs depending on the signal intensity. 
2.2.6 Semi-Quantitative RT-PCR  
With the exception of βe1-globin and elf1a, which were amplified for 23 cycles and 
served as positive and negative control respectively, semi-quantitative RT-PCR was 
performed for either 30 or 35 cycles at 95°C for 10 sec; 55°C for 20 sec; 72°C for 1 min. 
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Primers were designed according to the sequence provided by Affymetrix except lmo2, 
scl, flk1, gata1 and βe1-globin and elf1a (Table 2.1A). 
2.3 General RNA Application 
2.3.1 RNA Extraction from Embryos or Tissue 
Fish embryos or tissue were homogenized in TRI Reagent (Molecular Research Center) 
using 1ml syringes with 24 gauge needles. With the standard TRI Reagent RNA isolation 
protocol, about 50μg total RNA can be extracted from 100 1dpf fish embryos. These 
RNA were directly used for Northern Blotting analysis. For reverse transcription or 
microarray analysis, RNA was treated with DNAse I and further purified by using 
RNeasy Mini Column (Qiagen) to eliminate the contamination of genomic DNA.  
2.3.2 5’ and 3’ RACE (Rapid Amplification of cDNA Ends) 
5’ and 3’ RACE were performed by using SMART RACE cDNA Amplification Kit 
(Clontech) according to the manufacturer’s instructions. RACE primers for genes zvsg1 
and ncf1 were listed in Table 2.1B. The RACE products were cloned into pGEM®T-Easy 
Vector (Promega) for sequencing. Full-length sequences were aligned by program 
Seqman (DNASTAR Inc.).  
2.4 Whole Mount in situ Hybridization (WISH) 
2.4.1 RNA probe synthesis 
Plasmid DNAs were linearized by using the appropriate restriction enzyme (Table 2.2) 
and purified using the PCR purification kit (Qiagen). A 20μl RNA probe synthesis 
reaction contained 1μl RNA polymerase (Stratagene), 1μl RNAsin (Roche), 2μl 10X DIG 
or FLU RNA labeling mix (Roche), 4μl 5X reaction buffer, 1μg linerized plasmid DNA and 
nuclease free water. The reaction mix was incubated in a 37°C water bath for 2 hr. 1μl 
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DNase I (Roche) was then added to the reaction and further incubated at 37°C for 20 
min. The synthesized probe was further purified using a Millpore microcon (Millipore). An 
aliquot (0.5μl) of purifed probe was loaded onto a 1% agarose gel to determine its quality 
and quantity. Finally, the probe was diluted to a final concentration of 0.5μg per ml of 
WISH hybridization buffer (50% formamide, 5XSSC, 0.92mM citric acid, 0.1% Tween20, 
50μg/ml heparin and 500μg/ml tRNA) and stored at -20°C.  
2.4.2 Compact WISH Protocol for rag1 Screening 
4dpf fish embryos were fixed in 4% paraformaldehyde dissolved in PBS (PFA) either 
overnight at 4°C or 2 hr at RT. All washes were carried out at room temperature unless 
specified. Embryos were then washed 3x10 min in PBST (PBS with 0.1%Tween 20), 
followed by equilibrating in methanol for 5 min and stored in 100% methanol at -20°C for 
at least 20 min. At this stage, embryos can be kept for later use. To recover embryos 
stored in 100% methanol for in situ hybridization, they were washed in 50% and 30% 
methanol in PBST for 5 min each followed by 2x5 min washes in PBST. The methanol 
treated embryos were permeabilized by digestion with proteinase K (10μg/ml) for 20 min. 
After a brief wash in PBST, the embryos were subsequently fixed in 4% PFA for 20 min 
followed by 3x10 min washes in PBST. The embryos were pre-hybridized in WISH 
hybridization buffer (Hb) for at least 1 hr at 60°C. The pre-Hb was replaced with DIG-
labeled rag1 RNA probe (0.5μg/ml in WISH Hb) and the embryos were incubated 
overnight at 60°C. On the next morning, the RNA probe was removed and stored at -
20°C. These RNA probes could be reused for 3-4 times without notable decrease in 
hybridization signal. The embryos were washed 1x10 min in 2XSSCT at 60°C, then 1x10 
min in 0.2XSSCT at 60°C, and finally 1x10 min in PBST at RT. After post-hybridization 
wash, the embryos were blocked in 10% BCS/PBST at RT for 1 hr and then probed with 
anti DIG-AP antibody (Roche) at 1:2000 dilution in 10% BCS/PBST for 2 hr at RT. The 
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antibody was collected and stored at 4°C for reuse. Finally, the embryos were washed 
2x10 min in PBST, 2x10 min in buffer 9.5T (100mM Tris, 5mM MgCl2, 0.1%Tween20, pH 
adjusted to 9.5), and incubated with NBT/BCIP color substrate solution (one NBT/BCIP 
tablet (Sigma) in 10 ml DDW with 0.1% Tween20) in the dark at RT. The rag 1 signal 
could be seen after 1-2 hr of staining. 
2.4.3  High-Resolution WISH Protocol 
We applied a high-resolution WISH protocol from http://zfin.org to study temporal and 
spatial expression patterns of genes obtained from the microarray analysis. Fish 
embryos were collected at desired stages and dechorionated by pronase treatment. All 
washings were carried out at room temperature unless specified. The chorions were 
removed and the embryos were washed briefly in PBST before fixing in 4% PFA in multi-
wells in situ box (Figure 2.2B), which was specifically designed for in situ hybridization 
with different probes at same time. The fixed embryos were washed 2x5 min in PBST, 
1x5 min in 100% methanol, and then stored in fresh 100% methanol at -20°C for at least 
20 min. These dehydrated fish were re-hydrated with a series of methanol/PBST 
solutions (3:1, 1:1, 1:3) for 5 min each, and subsequently 2x5 min wash in PBST. 
Embryos were permeabilized by digestion with proteinase K (10μg/ml) for an appropriate 
time (Table 2.3). After a brief washing in PBST, the embryos were re-fixed in 4% PFA for 
20 min. The fixed embryos were washed 3X10 min in PBST before equilibrating in WISH 
Hb for 5 min at 60°C, and then changed into fresh WISH Hb and pre-hybridized for at 
least 1 hr at 60°C. Specific RNA probe (0.5μg/ml in Hb) was denatured at 68°C for 8 min, 
and cooled down on ice. The pre-Hb was discarded and the embryos were incubated in 
Hb with probe overnight at 60°C. On the next morning, the Hb with probe was recovered 
and stored at -20°C. The embryos were then washed as followed: 2x30 min in 
2X50%formamide/2XSSCT at 60°C, 3x20 min in 2XSSCT at 60°C, 2x30 min in 
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0.2XSSCT at 60°C, and 2x 5min in PBST at RT. After the washes, the embryos were 
incubated in blocking buffer (2% lamb serum in PBST) for at least 1 hr at RT, and 
followed by anti-DIG-AP antibody solution (1:2000 dilution in blocking buffer) overnight at 
4°C. After the overnight antibody incubation, the embryos were washed with PBST 6x20 
min at RT, and equilibrated with buffer 9.5T 2x10 min before detection. The embryos 
were incubated with NBT/BCIP substrate solution in the dark. Staining time could vary 
from 1/2 hr to overnight at 4°C depending on the probe used. The color reaction could 
be stopped by washing the embryos twice with PBST for 10 min each, followed by fixing 
with 4% PFA for 1 hr at RT. After 4x15 min wash with PBST, the embryos could be 
stored in 70% glycerol at 4°C for up to 1 month. For bright and clear signal, images of 
the embryos should be taken as early as possible. 
2.5 Microscopy and Photography 
LEICA MZ75 stereomicroscope was used for daily injection and embryo development 
monitoring. In situ or live fish pictures were captured by Spot Insight QE digital camera 
under LEICA MZ16 stereomicroscope. flk1-GFP transgenic fish was visualized under 
LEICA MZ FLIII fluorescence microscope, which a Nikon DXM1200F digital camera was 
attached to for fluorescence photography. For in situ stained embryo earlier than 10 
somites stage, the embryos’ bodies were separated from yolk, and then flat-mounted on 
the glass slides for holistic view.  
2.6 Single Embryo cDNA Library Construction 
2.6.1 RNA Extraction from Single Embryo 
Zebrafish embryos were collected from crossing one pair of wild-type or mutants 
crossing. At the stage of interest, single embryo was collected and put into individual 
1.5ml tube. Total RNA from each single embryo was prepared using the RNeasy Micro 
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Kit (QIAGEN) according to the manufacturer’s instructions. Typically, the final elution 
volume was about 10μl and contained 100-200ng total RNA. 
2.6.2 PCR Amplification 
Single Embryo cDNA library was constructed by using SMART PCR cDNA Synthesis Kit 
(Clontech). Firstly, RNA sample was transferred to a PCR tube and spun dry in an 
Eppendorf Concentrator. Reverse transcription reaction was set up in this PCR tube, 
which contained 1μl 3’SMART CDS Primer IIA, 1μl SMART II A Oligonucleotide (Table 
2.1C) and 3μl RNase Free water.  The reaction mix was denatured on Perkin-Elmer 
thermal cycler 9700 at 72°C for 2 min and then cooled down on ice for 2 min. The tube 
was spun briefly to collect all the contents at the bottom, and the following reagents were 
added: 2μl 5X First-Strand buffer, 1μl DTT (20mM), 1μl 50XdNTP (10mM) and 1μl 
PowerScript Reverse Transcriptase. The reaction mix was incubated at 42°C for 60-90 
min on the thermal cycler. After the reverse transcription, the mix was diluted by adding 
40μl of 1X TE and was ready for PCR amplification. The Long-Distance (LD) PCR 
reaction for cDNA amplification composed of 10μl 10X Advantage2™ PCR buffer, 2μl 
dNTPs mix (10mM), 2μl 5’PCR Primer IIA, 2μl Advantage2™ polymerase mix, 10μl first 
strand cDNAs as template and 74μl DDW. The LD PCR condition was 95°C 1 min 
followed by 15 cycles of 95°C 5 sec, 65°C 5 sec and 68°C 6 min. In order to determine 
the optimal number of PCR cycles for linear amplification of products, the PCR sample 
was removed after 15 cycles, and 20μl of the PCR reaction was aliquot into 4 PCR tubes 
(5μl in each tube), while the remaining 80μl was kept on ice. The 4 aliquoted PCR 
reactions were put back to the thermal cycler to continue the PCR amplification. At 
cycles 18, 21, 24, 27(15+3, 6, 9, 12), one PCR tube was taken out from thermal cycler 
and kept on ice. A total of 5 PCR samples from cycles 15-27 were analyzed on a 1% 
agarose gel to determine optimal number of PCR cycles. Good amplification products 
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should display a moderately strong smear of cDNA from 0.5 to 6kb, which means the 
amplification is in the exponential phase (Figure 2.3). In this case, the optimal cycle 
number was about 17-19. After amplification, semi-quantitative PCR or virtual Northern 
blotting was applied to verify the quality of amplified cDNA. 
2.7 Affymetrix Array and Data Analysis 
2.7.1 Sample Preparation 
For a non-amplified sample, the standard RNA extraction method as described in 
section 2.3.1 was used for the RNA preparation. The quality of the RNA extracted was 
examined by a spectrophotometer (NanoDrop). The ratio of Ab260:Ab280 should be 
between 1.8-2.2, and the ratio of Ab260:Ab230 should be above 2 for good quality of RNA. 
For an amplified sample, Single Embryo cDNA Library Construction approach was 
employed with the difference that SMART-T7-Anti-Sense Primer (Table 2.1C) was used 
instead of 3’SMART CDS Primer II A. 200μl of amplified PCR reaction was purified by 
PCR purification column (Qiagen), and the final yield of purified cDNA was about 2μg in 
RNase-Free water. A total of 10μg of non-amplified RNA or 1.5μg of single-embryo 
amplified cDNA were labeled with ENZO BioArray High Yield T7 RNA Transcript 
Labeling Kit (Enzo Life Sciences). 
2.7.2 Affymetrix Array 
The Zebrafish Genome Array (Affymetrix), containing 14,900 Danio rerio transcripts, was 
used as the chip for microarray. Array hybridization was performed according to the 
manufacturer’s instructions and the raw data was analyzed by using the Microarray Suite 
5.0 software. Spots with a ratio of greater than 1.5-fold (log ratio>0.6) were scored as 





Figure 2.3 Electrophoresis of Amplified cDNA from Single Embryo. A total of 5μl 
amplified single embryo cDNA (lanes 2,3,4,5) was examined on 1% agarose gel. 
Compared to the 1Kb ladder (lane 1), ethidium bromide staining displayes an evenly 
































Table 2.1 List of Primer Sequences 
 
A. 
Primers for cloning and semi-quantitative RT-PCR 
Gene Forward Primer Reverse Primer 
gata1 5'-actacaacactatggagacgc-3' 5'-acaacataatttacaagcttcg-3' 
lmo2 5'-ctgtgacctctgcggctg-3' 5'-acatttattgcaattgtgttac-3' 
flk1 5'-actcctcctctgaaatatatcagacc-3' 5'-acaggaaatgtgaatctctgaatgacc-3' 
scl 5'-acactgacggtatggaggtcag-3' 5'-aaagacgttgagctgcgccatc-3' 
βe1-globin 5'-acttcgccaagtttggaaacc-3' 5'-actgtcttcccagagcggac-3' 
actin 5'-accaccggtattgtgctggatgc-3' 5'-acagatccttacggatgtcaatgtc-3' 
elf1a 5'-cttctcaggctgactgtgc-3' 5'-ccgctagcattaccctcc-3' 
cld g 5'-ggcctctcgagctatccttgtcat-3'   5'-caaagacgatctcagacagacatt-3' 
mmp13 5'-atcaaaggtgagaaggtttgggct-3' 5'-ctcggattcttcttcaggcggtaa-3' 
yrk 5'-ctggaagctcaactagtttgcgtt-3' 5'-gctcagtgtaatagattggcacaa-3' 
copIII 5'-gatctgaccgaaggagaaaactca-3' 5'-caacagcactgtgctcgactcag-3' 
znfl2 5'-cgagcccgtgcacagcgaactgaa-3' 5'-cctggtgaactcctccatcatctc-3' 
dusp5 5'-gccatcatctcgcccaattttagc-3' 5'-caggcgctgataggcagaacatca-3' 
aqp8 5'-ctctggtcactgtcagcattgtga-3' 5'-gcgaagagacatttaagcatcagg-3' 
cahz 5'-ctgatcttctaaaactgtctgcgt-3' 5'-cctcttgatgaaaaaggaatcact-3' 
Dr.11977 5'-cggaaatgccttcaactgttgcca-3' 5'-catatttgcagaccaatatggcct-3' 
Dr.14448 5'-gccttcagaccgactctagatgct-3' 5'-gcagcacaatatcttacagcaact-3' 
Dr.14553 5'-ccagtcctaaagaggtggttcaca-3' 5'-gaaaagggatgatcaaagggtctg-3' 
Dr.16206 5'-caagcagtacagtgtgattgctcc-3' 5'-cactggtaacatgcagcaatatga-3' 
Dr.1870 5'-cttgttttcatgctgggctgcctt-3' 5'-cacatccagctcttcaacatgagg-3' 
Dr.2973 5'-ctcctgtttagcccagaacctgtt-3' 5'-gcatacttaagtagcctattgctg-3' 
Dr.25630 5'-ctgaattaggttattcctgaattg-3' 5'-ccattttgaaagcatgtgacagat-3' 
Dr.25117 5'-ctggagagagtctgattggctgga-3' 5'-ctgtggtgattctgatcatgcaat-3' 
Dr.6885 5'-gacctgtgagtcatgggcctacaa-3' 5'-gtgcccaaagaaattagaactaga-3' 















Primers for SMART cDNA Amplification 
3’SMART CDS Primer IIA 5'-AAGCAGTGGTATCAACGCAGAGTACT(30)VN-3'  (N = A, C, G, or T; V = A, G, or C) 




(24)VN-3’  (T7 promoter is underlined.) 
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Table 2.2 List of Constructs for WISH RNA Probes 
 
AFFX GENE ID GENE Vector Cutting Site RNA Polymerase 
Dr.8153.1.S1_at cldn g pDrive Sal I T7 
Dr.10314.1.S1_a_at mmp13 pCS2+ EcoRI T7 
Dr.6834.1.A1_at cpoIII pDrive BamH I Sp6 
Dr.3201.1.S1_at znfl2 pGEM-Teasy NcoI Sp6 
Dr.5365.1.A1_at dusp5 pGEM-Teasy Sal I T7 
Dr.2973.1.A1_at Dr.2973(ncf1) pGEM-Teasy NcoI Sp6 
Dr.916.1.S1_at aqp8 pCS2+ EcoRI T7 
Dr.450.1.S1_at cahz pGEM-Teasy Sal I T7 






Table 2.3 Duration of Proteinase K Permeabilization for Zebrafish Embryo 
 














Thymus plays an important role for T-cell development. T-cell lymphopoiesis and thymic 
organogenesis are crucial interdependent processes for the establishment of a 
functional vertebrate immune system. In mouse, lymphopoiesis starts from the 
pluripotent HSCs, which firstly home in the fetal liver and then migrate to the thymus for 
further proliferation and differentiation (Keller et al., 1999). With the interaction with the 
thymic epithelial cells (TECs), the immature lymphoid progenitors differentiate from 
double negative (CD4-CD8-) cells to double positive (CD4+CD8+) cells; subsequently, 
these CD4+CD8+ cells undergo positive and negative selection and finally become 
mature T lymphocytes (Douagi et al., 2002). The thymic development requires the inter-
communication from all the three embryonic germ layers: ectoderm, mesoderm and 
endoderm (Manley, 2000). Thymic developmental process can be separated into two 
stages: formation of the thymic rudiment and the interaction between T cells and thymic 
epithelial cells (TECs). In the first stage, neurectodermally derived neural crest cells 
(NCCs) from the sixth hindbrain rhombomere migrate to the third and fourth pharyngeal 
pouches, where they interact with endoderm to induce the formation of thymic rudiment. 
In the second stage, after the entry of T-cell precursors, blood vessels develop in the 
thymic rudiment, and subsequently the thymic epithelial cells differentiate into a three-
dimensional interdigitating to form the mature thymus. Only in this mature thymus 
microenvironment, the T lymphocyte precursors further proliferate and differentiate into 
mature T-cells (Manley, 2000).  
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Although many important factors or pathways involved in T-cell lymphopoiesis and 
thymic development have been uncovered, the genetic programs defining the early 
steps in these processes and TEC-T-cell interactions are poorly understood. To better 
understand the mechanism of the T-lymphoid program and thymic organogenesis during 
vertebrate development, we used zebrafish as the model organism to carry out forward 
genetic screen. Recombination activating gene (rag) 1 was selected as marker for this 
screen. The main function of RAG1 protein is to catalyze the V(D)J recombination of the 
immunoglobulin and T cell receptor (TCR) genes in immature B and T lymphocytes, 
respectively (Mombaerts et al., 1992). No mature T cell and B cell can be found in the 
rag1 knock-out mouse. rag1 is highly conserved across different species. The zebrafish 
Rag1 protein shares ~60% identity to mouse and human orthologues, and is specifically 
expressed in B and T cells (Willett et al., 1997a). Consistent with the mouse, the V(D)J 
recombination was impaired in the zebrafish rag1 mutant (Wienholds et al., 2002). Thus 
the zebrafish rag1 gene, having similar function as the mammalian counterpart, is 
required for B and T lymphocyte development. Given the fact that the expression of rag1 
can be easily detected by WISH in the thymus after 72hpf of zebrafish development 
(Willett et al., 1997b), it serves as an excellent genetic screen marker for mutations 
affecting development of thymus or its constituent lymphocytes. 
Through our in situ based genetic screen of 540 mutagenized zebrafish genomes, a total 
of 86 rag1 deficient mutant families were initially isolated. Considering the criterions of 
general development, blood circulation and thymus rudiment marker foxn1 expression, 
13 mutants were selected for future study.  
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3.2 Results 
3.2.1 ENU Mutagenesis and Family Generation 
The ENU-based mutagenesis protocol was shown to be the most effective mutagenic 
method in zebrafish. Through this protocol, point mutation in the zebrafish 
spermatogonia stem cells would be induced by alkylation on the genomic DNA (Deutsch 
et al., 1981). Since the frequency of ENU-induced mutations is dosage-dependent and 
the increment of ENU concentration from 2.0 to 3.0mM results in a significant increase in 
the mutation frequency, hence, we used 3.0mM ENU to achieve the high efficiency of 
mutagenesis. Forty healthy male wild-type AB fish were selected and treated with ENU 
as described in section 2.1.4.1. After three rounds of mutagen treatments, only 8 fish 
survived and one of them was sterile, which could be the result of high lethality rates 
caused by application of high ENU concentration. Hereafter, we were left with 7 founder 
fish to generate F1 progeny (Table 3.1). The mutagenesis efficiency was calculated by 
the frequency of induced pigmentation mutations by crossing the founder fish with 
pigmentation deficient mutant albino. This test should be done prior to the generation of 
F1 fish. However, in order to raise more F1 fish carrying more mutations, we performed 
this test after the generation of F1 fish, and the mutagenesis efficiency was found to be 
2/103, which was within the normal mutagenesis rates of 0.9-3.3X10-3 (van Eeden et al., 
1999). Considering the high mutagenesis efficiency existed even after the clearance of 
mutagenized sperm through the generation of F1, we assumed that the efficiency of our 
mutagenesis was possibly higher than 2/103. The mutagenized male fish were crossed 
with wild-type AB females to generate F1 progeny. To reduce the risk of raising progeny 
from spermatogonial clones, the number of F1 fish raised from each founder was limited 
to 150 fish, and hence, about 700 F1 fish were generated (Table 3.1). In order to save 
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space and reduce workload, we inter-crossed the F1 fish derived from different founders, 
and 330 F2 families were generated for genetic screen. 
3.2.2 rag1 Screen 
3.2.2.1 rag1 Whole Mount in situ Hybridization 
To screen for mutants affecting thymus formation or T lymphocyte development, we 
used rag1 as a marker gene to visualize the embryonic thymus by WISH. The 3 prime 
sequences, from nucleotides 1426 to 2944, of the zebrafish rag1 gene (NM_131389) 
were cloned into pBluescript II KS (+) vector. The DIG labeled anti-sense RNA probes 
were generated by in vitro transcription. Newly synthesized probes were tested to 
ensure a robust thymic expression of rag1 is displayed in every wild-type 4dpf fish 
(Figure 3.1) before being used for the screen. In general, about 20μg of rag1 probe was 
sufficient for each round of WISH to simultaneously screen 128 clutches of embryos and 
could be re-used at least 3 times. When the rag1 signal appeared slightly weaker than 
the previous screen, new probes was added to the old probe solution to maintain the 
strong and clear rag1 staining in the next round of screen.  
The forward genetic screen is a time and labor consuming process and requires a lot of 
space. In addition, the WISH based screen further complicates issues. In general, for our 
screen, the thymic expression of rag1 was best observed in at least 4dpf embryos and 
the normal WISH protocol took 3 days to complete; so taken together, the whole 
procedure lasted more than one week. In order to reduce the time and workload and 
maximize the available resources, we simplified the WISH protocol. As described in 
section 2.4.2, the post-hybridization washes and post-antibody washes were reduced, so 
the WISH took only 2 days, one day less than the standard protocol, to complete while 
retaining the strong intensity of the rag1 signal. Furthermore, we designed 64 and 96 






Figure 3.1 Thymic Expression of rag1 Gene in Zebrafish Embryos. 4dpf wild-type 
embryos were hybridized with DIG-labeled rag1 anti-sense probe. rag1 expression was 





simultaneously. Through these optimizations, we could screen more than 100 F2 
families within one week. 
3.2.2.2 The Primary Screen of rag1 Expression Deficient Mutants 
The general scheme of zebrafish genetic screen was illustrated in Figure 3.2. F3 
offsprings of each F2 family were screened for recessive mutations altering rag1 
expression in the thymus. Each F2 family constitutes sibling fish that share a gene pool 
of two mutagenized haploid genomes from each F1 parents and half of the fish in each 
F2 family are heterozygous for any particular mutation. Hence, sibling crosses within 
each F2 family will match two carriers of a mutation in a quarter of the matings (1/2X1/2), 
and a recessive mutant phenotype will be displayed by 25% of the F3 offsprings. The 
probability to identify a recessive homozygous mutation can be calculated using the 
formula 1 – 0.75n, where n is the number of successful cross. Theoretically, if 4 
successful crosses are screened in one F2 family, the chances to isolate this particular 
mutant will be about 70%. Therefore, we had set the criteria that at least four successful 
crosses should be screened in each F2 family (Table 3.1). Since the rate of success for 
crossing was about 40% in our fish, hence, to achieve 4 successful crosses, we had to 
set up at least 10 crosses from each family. After 3 months of primary screen, a total of 
1551 successful crosses from 270 F2 families had been screened and the average 
successful cross number achieved for each F2 family was 5.74. Applying this number to 
the formula 1 – 0.75n, the average probability to identify one mutation in our screen was 
81%. For the rest of the 60 F2 families, we could not successfully achieve enough 
crosses due to sex bias of the F2 offsprings. Through the primary round of screens, we 
identified 422 potential mutants that were distributed in 180 F2 families. This result 






Figure 3.2  Scheme of Forward Genetic Screen in Zebrafish.(Haffter et al., 1996) 
Males mutagenized with ENU were mated to wild-type females to generate the F1 
progeny. F2 families were raised from sibling matings. A mutation m present in one of 
the F1 parents was shared by 50% of the fish in the F2 family. Eggs were collected from 
a number of matings between sibling fish. If both parents were heterozygous for m, 
expected in ¼ of the crosses, ¼ of the eggs will be homozygous and show the mutant 
phenotype. For simplicity, a mutation carrier F1 fish mated with a wild type fish is shown 
here. In our experiment, both were heterozygous for a mutagenized genome. Therefore, 




3.2.2.3 Re-screen and Out-cross 
Rescreening of the 422 mutants identified from the first round of screens were of 
absolute necessity as the absence of rag1 signal observed might be due to spurious 
development abnormalities. Two additional rounds of screens were carried out to weed 
out false positive mutants. During the re-screens, mutant phenotypes were confirmed by 
at least two observers, and their in situ images and other morphological phenotypes 
were recorded in a mutant management database (see section 3.2.2.4). After two 
rounds of rescreens, 140 mutants from 110 families were confirmed. Although inter-
cross between two F2 mutants could generate more heterogeneous F3 progenies, 
however in practice, the viability and vigor of fish resulting from inbreeding was very 
much reduced compared to outbred fish. This was also true in the next generation, and 
therefore outcrossing to independent AB wild-type was performed to generate F3 
families. The generation of F3 families was not only for the maintenance of mutants, but 
also to further expurgate the genetic background of each mutant. The offsprings from 
each F3 family were re-screened from at least 8 successful crosses and an additional 24 
families were abandoned due to problems such as sterility, sex bias or absence of the 
mutant phenotype. The remaining 86 mutant families were confirmed to have reduced or 
absence of rag1 signal and were subjected to further, more detailed characterization.   
3.2.2.4 Data Management 
Genetic screening is a time, labour and resource-consuming task. To maximize benefits 
that we can reap from this screening, we collaborated with Dr Jinrong Peng whose group 
is interested in the study of liver development. While we carried out the rag1 screening in 
the embryos at 4dpf, Dr Peng’s group screened for their liver deficient mutants at 3dpf. 
Hence, we had to divide the embryos from each clutch of embryos among two groups. 
More than often, the embryos from a single cross was only enough for one group’s 
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screen and it was necessary to set up a new cross for this pair of fish on the following 
week. There were also incidents that a certain pair of mutants was identified to be 
carrying mutations of interest to both groups, and we needed to negotiate how we could 
assign this mutant for future characterization. Therefore, management of resources 
(such as fish and space) during genetic screen was a challenging but important issue. 
To deal with difficulties and complications arising from the screening procedure 
efficiently, a database management tool for data input was required to facilitate the 
mutant management and characterization. I developed a fish-screen/mutant 
management database by using File Maker Pro 5.0 (Filemaker Inc.) to assist us with the 
characterization and organization of our mutants. As illustrated in Figure 3.3, the 
database consisted of 3 features of each mutant: I) basic information of each mutant, 
which included the origin of founder, the birth of the mutants, the family number, the 
number of screens and the time of out-cross; II) morphological phenotype under 
microscope, which included general development status, the length of the body, the 
brain, eye and heart development etc.; III) other lineage markers test, which included 
blood circulation and foxn1 expression. All the parameters of each mutant were 
searchable to subgroup them, which made it easy for us to trace each pair of mutants 
during the screening. 
3.2.3 Initial Characterization of Mutants 
The thymus organogenesis requires the cross-talks of different cell types from all three 
germ layers and multiple factors are involved in this process. As shown in Figure 3.4, 
besides the rag1 deficiency, a large portion of the mutants also displayed many defects 
in other tissues or organs. Some mutants, like those in Figure 3.4 F,L,O, which had 
severe growth retardation or disorganization of body order, appeared to have multi-










Figure 3.3 Database Management of rag1 Screen. A fish screen/mutant management 
database was created by using File maker Pro 5.0. Panel A shows an example of a full 
data input built up during screen for a mutant. Panel B shows the summarized screen-
shot of the database in a compact format.  
 
 





































































































































































































































thymus. We are not interested in performing further analyses on these mutants with 
general defects. Based on careful considerations and stringent selections, we chose 1 
early blood defect mutant (260) and 12 morphologically relative normal mutants (180-3, 
193-1, 213-3, 174-6, 179-2, 161-6, 116-3, 262-3, 244-11, 194-2, 147 and 370) to carry 
out detailed investigations (Figure 3.5). Given the complexity and peculiarity of thymus 
and T cell development, we attempted to classify these 13 mutants into two groups: 
mutants with (I) thymic rudiment anomaly and (II) lymphoid lineage deficiency.  
We took advantage of in situ hybridization using transcription factor foxn1/whnb to help 
us identify mutants with thymic rudiment anomaly. It has been shown in mouse that the 
lack of foxn1/whnb causes a differentiation arrest and colonization failure in 
pro-thymocytes (Wortis et al., 1971; Nehls et al., 1994). WISH staining of foxn1 in 
zebrafish showed that the expression is also mainly localized in the thymic rudiment 
(Schorpp et al., 2002), indicating a similar function by zebrafish foxn1 to that of mouse. 
We examined all the 13 mutants and found that although the expression patterns of 
foxn1 appeared to be in a condensed manner in the thymic rudiments in some mutants 
(Figure 3.6), all 13 mutants maintained the foxn1 transcripts. This result suggested our 
mutants have normal thymus epithelial cell development and the rag1 deficiency 
phenotype should be attributed to the hematopoietic lineage cell abnormality. 
Based on our preliminary characterization by the presence of intact thymic rudiments in 
the mutants, all 13 mutants are categorized under group II. The mutations affecting the 
group II mutants could result in defects in the hematopoietic stem cells, common 
lymphopoietic progenitor (CLP), or T-cell lineage cells. To determine if the mutants had 
defective hematopoietic stem cells, we examined defects in the erythroid lineage by 
visualizing the blood circulation in the mutants at 2dpf under stereomicroscope. One 





































































































































































































































Figure 3.6 foxn1 Expression in Wild-Type and Mutant. RNA whole mount in situ 
hybridization on 5dpf wild-type embryo shows that the foxn I expression is located in the 
thymus (left panel). Although all 13 mutants exhibited the foxn1 staining, the expression 








confirmed by o-dianisidine staining (Figure 3.7), which reacts with mature hemoglobin 
protein to produce a red coloration (Detrich, III et al., 1995). The lack of red blood cells 
indicated that this mutant has deficiency in both erythroid and lymphoid lineage cells and 
strongly suggested that the mutation causes defects at the hematopoietic stem cell level. 
Positional cloning revealed that the responsible gene for this mutation encoded a novel 
gene with unknown function (unpublished data, Liu Y.M.). The remaining 12 mutants 
have seemingly normal development of erythroid lineage cells based on the red blood 
circulation suggesting that their mutations cause deficiencies in the CLP or the lineage 
cell migration.  
3.3 Discussion 
Our genetic screen was designed for isolating T-cell or thymus defective mutants based 
on whole mount in situ hybridization of rag1 expression in the zebrafish thymus region. 
As rag1 expression in immature thymocytes required both normal development of T cell 
precursors and an appropriate microenvironment for the thymus anlage, our rag1 
deficient mutants were expected to possess defects in T-lymphoid cell development or 
thymus formation. 
Through our genetic screen, 86 mutants were confirmed both in the F3 and F4 
generation. However, many of them were accompanied by developmental retardation. 
Since the thymic development requires the contribution of tissues from all three germ 
layers, thus, any defects in endoderm, mesoderm and ectoderm development may also 
affect the body formation as well as normal development of thymus. Hence, some of our 
mutants may have general defects in germ layer formation and may not have specific 
functions in thymogenesis. Based on this criterion, 12 morphologically normal mutants 
(180-3, 193-1, 213-3, 174-6, 179-2, 161-6, 116-3, 262-3, 244-11, 194-2, 147 and 370) 








Figure 3.7 o-dianisidine Staining on 2dpf Wild-Type and Mutant 260. The o-
dianisidine stains the erythroid cell containing hemoglobin and develops brown 
coloration. In wild-type embryo, the stained erythroid cell can be seen to be distributed in 
the heart (H), common cardinal vein (CCV), posterior cardinal vein (PCV) and dorsal 
aorta (DA) (upper panel). In mutant 260, the erythroid cells are dramatically decreased 










mutant, 260, as it has dramatic decrease in the number of the primitive erythroid cells 
(Figure 3.7), making it a potential HSCs deficient mutant, despite its severe phenotype 
during early development. 
Although foxn1 expression, a thymus epithelial cell marker, was positive in all the 
mutants, its expression in some of the mutants appeared to be smaller and condensed. 
This phenotype was similar to the foxn1 expression in HSCs deficient mutant cloche 
(Schorpp et al., 2002), suggesting the thymus rudiment formation in these mutants are 
normal, but failed to further expand due to the absence of T cell precursors. In addition, 
the normal morphology of the 12 mutants also suggested that the pharyngeal epithelial 
cells could develop normally and form the thymus rudiment. Thus, the initiation of the 
thymus rudiments in our mutants were not affected, and the main defects could be either 
on the T lymphocyte precursors or the migration of these precursor cells.  
Through the observation of blood circulation, we have shown that with the exception of 
mutant 260, the 12 morphologically normal mutants have normal primitive blood cell 
development, which indicate their defects could be specifically in the lymphoid lineage 
cells. However, we did not examine the blood circulation after 5dpf when the definitive 
red blood cells start to proliferate (Weinstein et al., 1996). Therefore, although the 
primitive blood formation is normal in these 12 mutants, they may have defects in both 
definitive erythropoiesis and lymphopoiesis. Most of our mutants died within 10dpf, 
which may be due to developmental failure in other organs. This early lethal phenotype  
makes it impossible for us to examine the mutation in B lymphocyte development since 
B lymphocytes in zebrafish are first detected in kidney by rag1 expression on 21dpf 
(Willett et al., 1999). Considering the zebrafish rag1 mutant can survive to adulthood 
without special attention (Wienholds et al., 2002); the early lethal phenotype of our 
mutants exclude the possibility that their corresponding genes for the mutations are rag1 
itself.  
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3.4 Conclusions and Future Work 
13 mutants, comprising one HSCs mutant and 12 lymphoid precursor mutants, are 
selected for future analysis. Since the 12 lymphoid precursor mutants are morphological 
normal and similar, complementation test should be fulfilled before detailed 
characterizations and positional cloning are carried out. In addition, it is also important to 
further characterize these mutants using other molecular approaches. Histological 
section can help us define the disrupted cell population in the mutant thymus, whereas 
lymphoid cell migration and homing can be examined by cell transplantation. Studies 





Table 3.1 Summary of rag1 Genetic Screen 
 
 Number 
Founder Fish 7 
F1 Fish ~700 
F2 Families 330 
Screened F2 Families 270 
Successful Crosses 1551 
Successful Crosses per Family 5.74 
Primary Identified Mutants 422 
Identified Mutants Family 180 
Rescreen Confirmed Mutants 140 
Rescreen Confirmed Mutants Family 110 
Identified F3 Mutants Family 86 





4 Chapter IV: Microarray Analysis of Gene Expression 
Profiles in Zebrafish cloche Mutant 
 
4.1 Background 
Zebrafish serves as an excellent model organism for the study of early hematopoiesis 
development in vertebrate. So far, more than 30 hematopoiesis-defected zebrafish 
mutants have been isolated (Ransom et al., 1996; Weinstein et al., 1996), of which the 
cloche (clo) mutant has one of the most interesting phenotypes (Stainier et al., 1995). 
The zebrafish clom39 mutant was originally isolated from an Indonesian fish farm in 
search for spontaneous mutations affecting early development, and till now, 2 more 
alleles (clos5, clom378) were identified by Stainier and Driever’s group. Molecular and 
genetics studies showed that clo acts upstream of stem cell leukemia (scl) and 
endothelial growth factor (VEGF) receptor flk-1, and is required for the development of 
both hematopoietic and endothelial lineage cells (Liao et al., 1998; Thompson et al., 
1998), implying that the clo mutation affects development of the hemangioblast, a 
common progenitor of hematopoietic and vascular endothelial cells. Hence, cloning of 
the clo gene and identification of its downstream targets will shed light on our 
understanding on the molecular basis underlying the initiation and differentiation of 
hematopoietic and endothelial lineages as well as subsequent specification of the 
distinct blood cell types. With the availability of zebrafish cDNA Microarray and 
Affymetrix array, gene expression profiling analysis would be a powerful approach to 
identify downstream target genes perturbed in clo mutants. Since most of early 
hematopoietic events occur before 24 hr in zebrafish and it was hard to differentiate clo 
mutant from wild-type sibling based on morphology before 24 hpf, isolating large 
numbers of clo homozygous mutant embryos at the early stage became a big obstacle 
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for early gene profiling analysis. To overcome this restriction, I developed a method 
using amplified cDNA probes derived from single embryo for gene expression 
comparative analysis on the 18-somite clo mutant and wild-type sibling embryos. The 
study resulted in identification of the 13 clo downstream target genes that have not been 
reported previously. We further showed that this amplified cDNA approach is 
comparable and complementary to that of the conventional unamplified method using 
large numbers of pooled embryos, demonstrating that it is well suited for zebrafish 
embryo gene expression profiling analysis. 
4.2 Results 
4.2.1 Single Embryo cDNA Library Construction 
The method for the single embryo cDNA library construction was adapted from SMART 
(switching mechanism at the 5’ end of the RNA transcript) technology (Clontech), which 
takes advantage of the template-switching activity of Moloney Murine Leukemia Virus 
(MMLV) reverse transcriptase to synthesize and anchor first-strand cDNA in one step 
(Zhu et al., 2001). The strategy for this method is illustrated in Figure 4.1. The first-
strand cDNA synthesis is carried out in the presence of two oligonucleotides: a “lock-
docking” primer that contains a universal sequence and oligo-d(T), and an SMART II A 
oligonucleotide that contains the universal sequence. When reverse transcriptase 
reaches the 5’end of the mRNA, the enzyme’s terminal transferase activity adds 
additional nucleotides (predominantly dCTP) that are not encoded by the template. The 
SMART II A oligonucleotide contains three consecutive rG nucleotides at the 3’ end to 
serve as a second template for reverse transcriptase. When reverse transcriptase 
reaches the 5’ end of the mRNA, the complementary interaction of the r(G)3 stretch at 
the 3’ end of the SMART II A oligonucleotide and dC-rich extended sequence of the 






Figure 4.1 Scheme of the SMART cDNA Library Construction Method. (Adopted 
from SMART™ PCR cDNA Synthesis Kit User Manual, Clontech, 2001) 
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oligonucleotide, adding the universal sequence as an anchor to the end of first-strand 
cDNA. The resulting full-length, single-stranded (ss) cDNA contains the universal 
sequence at both the 5’ and 3’ ends. This anchor sequence is then used as priming sites 
for end-to-end cDNA amplification by long-distance PCR to generate the amplified single 
embryo cDNA library. To ensure each sample was amplified properly, cDNA within the 
exponential phase was examined by electrophoresis and result showed that each 
amplified sample yielded an evenly distributed smear of DNA (Figure 2.3). Virtual 
northern by using low-abundance marker gata1 and large size marker flk1 (4.6kb) also 
ascertained that the cDNA library was well constructed (Figure 4.2).  
4.2.2 Isolation of 18hpf clo Homozygous Mutant Embryos 
Previous studies by whole-mount in situ hybridization analysis have shown that many 
early hematopoiesis-specific genes, such as scl, gata1 and embryonic globins, appear to 
express more abundantly from 18hpf to 24hpf in wild-type fish, but be down-regulated in 
clo mutant (Thompson et al., 1998). We therefore chose to compare the gene 
expression profile of the 18-somite clo mutant and wild-type/heterozygous sibling 
embryos in the hope of increasing the possibility of identifying potential target genes 
involved in early hematopoiesis. One difficulty, however, was to isolate large numbers of 
the 18-somite stage clo homozygous mutant embryos due to their indistinguishable 
morphology from the wild-type/heterozygous siblings before 24hpf. To solve this problem, 
18hpf single embryo was randomly collected from mating of two heterozygous clo adult 
fish and homogenized to extract total RNA. To distinguish the clo mutant from wild-type 
sibling embryos, each RNA sample was ‘genotyped’ by examining the expression of flk1, 
scl, lmo2, gata1 and βe1-globin that are known to be either absent or greatly reduced in 
clo mutant at this stage. As shown in Figure 4.3, semi-quantitative RT-PCR assays 










Figure 4.2 Quality Examination of Single Embryo cDNA Library by Virtual Northern. 
Amplified cDNAs from single embryo were transferred to the Hybond-N+ membranes. 
Virtual Northern was used to examine the quality of each constructed cDNA library using 
flk1 and gata1 as probes, while elf1a was used as loading control. The strong detection 
of large size transcript flk1 and low abundant gene gata1 indicated the good quality of 
amplification. The absence of flk1 and gata1 bands in lanes 2 and 4 indicated these two 

























Figure 4.3 “Genotyping” of the 18-Somite clo Homozygous and Wild-
Type/Heterozygous Sibling Embryos by Semiquantitative Reverse Transcriptase-
Polymerase Chain Reaction (RT-PCR). Equal amount (1/10) of cDNA from the 
randomly selected single 18-somite embryo was subjected to semiquantitative PCR 
analysis with specific primers for zebrafish flk1, scl, lmo2, gata1, and βe1-globin. actin 
and elf1a were used as control to indicate the amount of cDNA used. Lanes 4, 7, and 9 
are clo mutants, whereas the other lanes (lanes 1,2,3,5,6,8,10,11 and 12) represent 
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scl, lmo2, gata1 and βe1-globin. In fact, of the 96 samples examined, 23 lacked 
expression of the five mentioned genes. This number is close to the expected Mendelian 
segregation ratios. Subsequently, cDNAs from potential clo or sibling single embryo 
were amplified by single embryo cDNA library construction method. After that, each 
constructed cDNA library was qualified by DNA electrophoresis and virtual northern blot 
assay (Figure 4.4). The virtual northern results confirmed that the RNA samples deficient 
in flk1, scl, lmo2, gata1 and βe1-globin expressions were indeed derived from the clo 
homozygous mutant embryos, whereas others represented the wild-type/heterozygous 
sibling embryos, and the amplified cDNAs were of good enough quality for further 
Microarray analysis. 
4.2.3 Affymetrix Array Using Amplified Approach  
In order to reduce the variation of the microarray analysis, five of the single embryo 
cDNAs from the clo mutant embryos or wild-type/heterozygous siblings were pooled 
together and subjected to PCR amplification. A pair of modified universal primers, in 
which a T7 promoter sequence was inserted in the 3’ primer (Table 2.1C), was used for 
PCR amplification so that probe labeling could be carried out by in vitro transcription with 
T7 RNA polymerase. To ensure each sample was amplified properly, DNA within the 
exponential phase was examined by electrophoresis and result showed that each 
amplified sample yielded an evenly distributed smear of DNA (Figure 4.4A). Virtual 
Northern blot analysis confirmed that flk1, gata1 and βe1-globin transcripts remained 
either undetectable or greatly reduced in the clo mutant samples after amplification 
(Figure 4.4B), indicating that the amplified cDNA samples were well constructed. The 
amplified cDNAs were then biotin-labeled by in vitro transcription with T7 RNA 
polymerase and applied on the Affymetrix chip representing ~14,900 zebrafish unique 







Figure 4.4 Analysis of Amplified cDNA Quality. A: DNA electrophoresis analysis. 
100ng of each amplified cDNAs derived from the single 18-somite clo homozygous 
mutants (lanes 2, 4 and 6) and wild type or heterozygous sibling (lanes 1, 3 and 5) was 
separated on 1% agarose gel. Ethidium bromide staining shows an evenly distributed 
smear of DNA in each lane. B: Virtual Northern analysis. cDNAs of (A) were transferred 
to a Hybond-N+ membrane and probed with digoxingenin-labeled flk1, gata1, βe1-globin 
and actin. While elf1a transcript was maintained at a similar level in all the samples, 
expression of flk1, gata1 and βe1-globin were either absent or drastically reduced in clo 






calculated using Affymetrix Microarray Suite 5.0 Software (MAS 5.0) and the spots with 
a ratio of greater than 1.5-fold were scored as positive. Three sets of independent 
experiments were performed and those clones scored positive in at least two of the three 
experiments were selected as potential differentially expressed targets. In total, 37 
potential down-regulated targets were identified. Among these clones, 18 of them (listed 
in Table 4.1 under category I) are well-known early hematopoiesis- and endothelial-
related genes arrayed on the Affymetrix chip. There was no obvious up-regulated clone 
found from the Affymetrix arrays. To evaluate the reproducibility of Affymetrix array, R2 
values of any two experiments were calculated. The consistent results, 0.9830, 0.9777, 
0.9859 from each comparison, indicated that our Affymetrix array results were 
reproducible. 
4.2.4 Affymetrix Array Using Conventional Approach 
To further evaluate the result obtained by the amplified approach, we sought to compare, 
in parallel, with the standard method using large numbers of pooled embryos. 
Fortunately, we have generated a heterozygous clo line carrying the homozygous EGFP 
transgene under the control of the zebrafish flk1 promoter (Jin et al., 2005b), in which 
the 18-somite clo homozygous embryo can be distinguished from wild-type and 
heterozygous sibling based on alteration of the EGFP expression under the 
stereomicroscope (Figure 4.5). Total RNA was prepared from one hundred 18-somite clo 
homozygous embryos or the wild-type/heterozygous siblings, labeled with biotin 
according to the manufacture’s protocol and applied onto the Affymetrix chip. Similar to 
the single embryo method, three sets of experiments were conducted. Through software 
analysis, we found 39 potential targets, among which included 22 well-known early 








Figure 4.5 Vascular Expression of Tg(flk1:EGFP) in Wild-Type and clo Mutant at 
2dpf and 18-somite stage. In 2dpf wild-type flk1 promoter driven transgenic fish (upper 
fish in panel A), EGFP expression can be visualized in all the blood vessels, whereas in 
the clo mutant (lower fish in panel A), only part of the vessels in the gill and tail regions 
have EGFP expression. At 18-somite stage, both anterior lateral mesoderm (ALM) and 
posterior later mesoderm (PLM) have EGFP expression in wild-type embryo (panel B), 





are 0.9921, 0.9835 and 0.9761, evidently demonstrated that our conventional method is 
as reproducible as single embryo methods when applied on Affymetrix arrays. 
4.2.5 Affymetrix Results Validation 
Although Affymetrix array showed a total of 49 genes down-regulated in clo mutant from 
both methods, the validity of these results need to be corroborated by other approaches. 
We examined the expression level of these potential clones by semi-quantitative PCR, 
and found that 84% (31/37) and 90% (35/39) of the clones from the amplified and 
conventional methods, respectively, were indeed differentially expressed in clo mutant 
and wild-type/heterozygous sibling (Figure 4.6). Further comparison between the PCR 
confirmed clones from both methods revealed that 26 of the 31 clones identified by the 
amplified approach overlapped with those obtained by the conventional unamplified 
method. In summary, 40 clones were found to be down-regulated in clo mutant (Table 
4.3).  
4.2.6 Amplified Vs Conventional Approach 
To collate the Affymetrix results from amplified and conventional methods, firstly, we 
investigated the standard array quality metrics, including Raw Q, Background, Scaling 
Factor, Percent Present Call, GAPDH 3’/5’ ratio and actin 3’/5’ ratio. As shown in Table 
4.2, these parameters were all comparable and within the appropriate range, indicating 
that both approaches gave rise to similar array quality. Next, we examined the Signal 
Intensities of any given two experiments obtained within each approach and results 
showed that their patterns and R2-values (0.9830 and 0.9921 for amplified and 
unamplified methods, respectively) were comparable (Figure 4.7), affirming that the 
reproducibility of the amplified approach was similar to that of the standard unamplified 






Figure 4.6 Verification of Target Clones by Semi-Quantitative RT-PCR. 1μg of total 
RNA sample (20 embryos/each) derived from the wild type sibling (lanes 1 and 3) and 
clo mutant embryos (lanes 2 and 4) were reverse transcribed and subjected to PCR 
analysis with specific primers corresponding to each of the perspective target genes. 
PCR products were electrophoresed on 1% agarose gel and stained with ethidium 









Figure 4.7 Reproducibility of Affymetrix Arrays. The scatter plots of signal intensity 
were generated to assess the reproducibility of duplicated samples. A-B: Comparison of 
any two experiments of either the approach with limited embryos (A) or standard 
unamplified method (B) shows that the scatter plot patterns and R2-values between two 
experiments of each approach are similar with the majority of the present spots (red 





identified by the amplified approach were common among those of the 35 clones from 
conventional method, also gave similar conclusion. These results clearly demonstrated 
that the amplified approach is comparable to the conventional method. Remarkably, 
although majority of positive clones were detected by both method, there were still 14 
clones uncovered only by one method (5 from amplified method and 9 from conventional 
method), suggesting that the amplified approach is also complementary to that of the 
conventional unamplified method.  
4.2.7 Gene Expression Analysis 
After microarray analysis and semi-quantitative PCR confirmation, a total of 40 clones 
showed absence or dramatic decrease in expression in clo mutant. Among these 40 
clones, 22 of them are well-known early hematopoiesis- and endothelial-related genes. 
Since the involvement of a gene during development could be indicated by its 
expression pattern, temporal and spatial expressions of the remaining 18 differentially 
expressed clones were investigated by whole-mount in situ hybridization analysis. WISH 
results showed that nine target genes, coproporphyrinogen oxidase (cpo), carbonic 
anhydrase (cahz), claudin g (cldn g), zinc finger-like gene 2 (znfl2), neutrophil cytosol 
factor 1 (ncf1), matrix metalloproteinase 13 (mmp13), dual specificity phosphatase 5 
(dusp5), aquaporin 8 (aqp8) and Dr.9655 (Dailey, 2002; Peterson et al., 1997; Kollmar et 
al., 2001; Yoda et al., 2003; Volpp et al., 1989; Leeman et al., 2002; Kwak and Dixon, 
1995; Sudol et al., 1993; Yang et al., 2005) were predominantly expressed in 
hematopoietic and vascular endothelial cells.  
As shown in Figure 4.8, znfl2, cldn g, cpo and cahz are erythrocyte-specific. znfl2 was 
first detected at 3-somite stage as a single pair of stripes in the posterior lateral 
mesoderm (Figure 4.8A). The two stripes subsequently extended anteriorly and 





































































































































































































































































































































































































































































































































somite stage (Figure 4.8 B,C). Its transcript was clearly reduced by 30hpf (Figure 4.8D). 
This expression is similar to the pattern of the early erythrocyte marker gata1 (Detrich, III 
et al., 1995), suggesting that znfl2 is expressed in erythrocyte. The cldn g, cpo and cahz 
transcripts emerged later at around 10- (cldn g and cpo) to 14-somite stage (cahz) as 
two stripes in the posterior lateral mesoderm, extended toward both anterior and 
posterior directions and fused at around 18- to 20-somite stage (Figure 4.8 H,I,N,O,T). 
Similarly, their transcripts were reduced in the ICM region by 30hpf (Figure 4.8 J,P,U), a 
pattern more similar to that of embryonic globin (Brownlie et al., 2003). As expected, 
expressions of znfl2, cldn g, cpo and cahz were either absent or greatly reduced in the 
clo and erythrocyte-deficient moonshine (mon) (Ransom et al., 2004; Ransom et al., 
1996; Weinstein et al., 1996) mutant embryos (Figure 4.8 E,F,K,L,Q,R,V,W). Taken 
together, these observations demonstrate that znfl2, cldn g, cpo and cahz are 
predominantly expressed in erythroid lineage cells. Notably, in addition to the ICM, the 
cahz transcript was also detected in the otic capsule where its expression remained 
unchanged in the clo and mon mutant embryos (Figure 4.8 T,V,W). The biological 
meaning of this otic capsule expression, however, is unclear. 
Both mmp13 and ncf1 appear to fall into the myeloid-specific group of genes (Figure 4.9). 
The mmp13 transcript was first detected at around the 10-somite stage in the region 
close to the rostral blood island where the primitive myeloid lineage is believed to arise 
(Lieschke et al., 2002) (Figure 4.9A). At the 18-somite stage the number of mmp13-
positive cells increased and scattered around the anterior region of the yolk sac (Figure 
4.9B). By 36hpf a small number of mmp13-positive cells began to emerge in the 
posterior region of the ICM (Figure 4.9C). Thus, mmp13 is expressed in a manner 
similar to that of the myeloid lineage marker pu.1 from 10- to 18-somite stages (Lieschke 
et al., 2002) and lysozyme-C at 36hpf (Liu and Wen, 2002). The ncf1 displayed an 
overlapping but slightly distinct expression pattern compared to mmp13. It emerged at 
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around the 14-somite stage in the rostral blood island region, increased and scattered 
around the anterior region of the yolk sac at 18- to 20-somite stage (Figure 4.9G). 
However, by 36hpf the ncf1 expression was almost undetectable (Figure 4.9H). Given it 
emerges from the region close to the rostral blood island and the mammalian 
counterpart is highly expressed in neutrophil (Heyworth et al., 2003), we believe 
zebrafish ncf1 is also expressed in myeloid lineage cells. To provide additional evidence 
to support the argument that mmp13 and ncf1 are myeloid lineage-specific, whole-mount 
in situ was also carried out on the 18-somite stage clo and mon mutant embryos. Our 
result showed that, while expression of mmp13 and ncf1 was absent in the clo mutant 
embryos (Figure 4.9 D,I), their transcripts remained unchanged in the erythrocyte-
deficient mon mutant embryos (Figure 4.9 E,J). These results show that both mmp13 
and ncf1 are specifically expressed in myeloid lineage.   
The last three genes, dusp5, aqp8 and Dr. 9655, are vessel enriched genes. As shown 
in Figure 4.10, the transcript of dusp5 was first detected at around 3-somite stage as two 
pairs of stripes, one in the head and another in the lateral mesoderm (Figure 4.10A). In 
the head region, the dusp5-expressing cells were mainly localized anteriorly and 
posteriorly to the eye (Figure 4.10B). Intriguingly, at around 6- to 8-somite stages, a third 
pair of stripes along the inner region of the lateral mesoderm stripes began to emerge 
(Figure 4.10B). The outer bilateral pairs of stripes, which appeared similar to the lateral 
mesoderm stripes representing the hematopoiesis-endothelial cells, extended anteriorly 
and posteriorly from 10-somite stage onward and converged in the midline at around the 
18 to 20-somite (Figure 4.10C). By 24hpf, dusp5 was mainly expressed in the trunk as 
two stripes where the dorsal aorta and axial vein forms (Isogai et al., 2001) (Figure 
4.10D). This expression pattern is particularly similar to that of vascular endothelial 
marker fli1 (Brown et al., 2000), suggesting that dusp5 is likely to be expressed in 
vascular endothelial cells. This argument was further supported by the finding that the 
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dusp5 transcript was absent in the 18-somite stage clo but not erythrocyte-deficient mon 
mutant embryos (Figure 4.10 E,F). The inner lateral stripes behaved similarly to the biklf-
enriched inner stripes (Kawahara and Dawid, 2000). It appeared at around 6- to 8-
somite and soon diminished by 18-somite stage. As expected, the inner stripes were not 
affected in both clo and mon mutants, indicating that they might not be hematopoietic 
and endothelial lineage cells. In contrast to the broad temporal and spatial expression of 
dusp5, another two genes, aqp8 and Dr.9655, in this group displayed an expression 
more concentrated in the blood vessel endothelial cells. At 18-somite stage, aqp8 is 
expressed in the blood vessel endothelial precursors at ICM region, more substantially in 
dorsal aorta (Figure 4.10L). At 22hpf, both the dorsal aorta and posterior cardinal vein 
were stained with equal density of the aqp8 transcripts (Figure 4.10M). This expression 
pattern of aqp8 was very similar to that of the vascular endothelial marker flk1. The last 
gene, Dr. 9655, in this group began to express as a cluster of cells in the position 
between the third and fourth somite at 14-somite stage (Figure 4.10G). These Dr. 9655-
positve cells extended posteriorly from 18-somite onwards and were subsequently 
detected in the dorsal aorta, choroidal vascular plexus and intersegmental vessel by 
36hpf (Figure 4.10I). Similar to dusp5, Dr.9655 transcript was absent in the clo mutant 
embryos but was not affected in the mon mutant embryos (Figure 4.10 J,K). In summary, 
the observations clearly show that dusp5, aqp8 and Dr. 9655 are specifically expressed 
in vessels and may play roles in vasculargenesis and angiogenesis. 
Taken all together, the whole-mount in situ analyses demonstrate that the nine target 
genes (cpo, cahz, znfl2, cldn g, mmp13, ncf1, dusp5, aqp8 and Dr.9655) are indeed 
down-regulated in the clo mutant embryos, which are in consistence with the semi-
quantitative RT-PCR analyses. Thus, we believe that the remaining nine clones (yrk,      
Dr. 6885, Dr. 11977, Dr. 25117, Dr.1870, Dr. 14448, Dr.14553, Dr.16206 and Dr. 25630), 
 91
although they fail to show specific expression pattern in whole-mount in situ hybridization, 
are also most likely to be down-regulated in clo mutant.  
4.2.8 Sequence Analysis and Generation of Full-length cDNA Clone  
To explore the genome structure and mammalian orthologue of these target genes, I 
blasted their sequences over two zebrafish genomic servers, NCBI 
(http://www.ncbi.nlm.nih.gov/genome/guide/zebrafish/index.html) and Ensembl 
(http://www.ensembl.org/Danio_rerio/index.html), which contain the latest and most 
comprehensive resources of zebrafish genome, ESTs and genes (Table 4.4). Through 
genomic blasting, all clones, except Dr.25117, were located on a certain lineage groups 
(Table 4.4). Moreover, 13 clones (cld g, mmp13, yrk, cpo, znfl2, dusp5, aqp8, cahz, ncf1, 
Dr.11977, Dr.16206, Dr.9655, Dr.25117) have full-length cDNA sequences in GeneBank, 
and their Gene IDs were listed in Table 4.4. To examine their functions from detailed 
sequence analysis, T-coffee multiple sequences alignment program was applied to 
achieve protein comparisons among different organisms (Poirot et al., 2004). As shown 
in Figure 4.11, 9 out of the 18 newly identified target genes, including cpo, cahz, cldn g, 
znfl2, ncf1, mmp13, dusp5, aqp8 and yes-related kinase (yrk) are known genes that 
have high homology to their mammalian counterparts and have been reported in other 
vertebrate species, but the functions relating to hematopoiesis and vessel development 
for most of these genes have yet to be fully illustrated. In addition, clone Dr.16206 is 
predicted similar to embryonic transglutaminase and with about 50% identity to mouse 
coagulation factor XIII; clone Dr.25117 matches a mammalian cDNA sequence that is 
predicted to encode a hypothetical protein (FLJ13263), whereas clone Dr. 11977 shares 
low similarity (35% identity) with a functional unknown human ELLP3030 cDNA. No 
mammalian homologues were found for the remaining six clones, Dr.6885, Dr.9655, 
Dr.25630, Dr.1870, Dr.14448 and Dr.14553, suggesting that they either contain partial 
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sequences, probably a noncoding region in this case, or encode genes that are unique 
to fish. To further investigate these six genes, 5’ and 3’ RACE were carried out to 
generate the full length cDNA clones. So far, only one full length cDNA clone, Dr.9655, 
which contains 1910 nucleotides and encodes a protein of 410 amino acids, was 
obtained from RACE. Since there is neither mammalian homologue nor annotations from 
the zebrafish database, based on the expression pattern of this gene, we named it as 
zvsg1, acronym for zebrafish vessel-specific gene 1, and the sequence was submitted to 
Genbank with accession ID NM_001014364.  
4.3 Discussion 
4.3.1 Single Embryo Approach 
With the wide, growing interest in large scale genomic research, robust and reliable 
methods to isolate and manipulate small amount of samples need to be developed. 
Although amplification processes through in vitro transcription or PCR have been 
described in tissue culture or laser ablation cells(Wang et al., 2000; Iscove et al., 2002), 
method suitable for zebrafish embryos has yet been reported. Here I described a 
method using amplified cDNAs from single embryo to compare the gene expression 
profiles of the 18-somite clo mutant with wild-type/heterozygous sibling embryos on 
Affymetrix DNA microarray. Our results show that this amplified approach is able to 
identify differentially expressed genes in a manner similar to that of the standard 
unamplified method. 
Among the 37 potential clones from single embryo arrays, 31 of them were confirmed by 
semi-quantitative RT to be down-regulated in clo mutant compared to the wild-
type/heterozygous sibling. Hence, the ratio of true positive clones is 84% of the potential 
candidates and this is comparable to that of conventional approach at 90% (35/39). 
Although, with the exception of plexind I, band4.1, ikaros and hhex, the amplified 
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approach had successfully identified 18 early well-known hematopoietic- and 
endothelial- related genes arrayed on the Affymetrix chip that served as positive controls 
and this largely assured the quality of the array results. Failure to detect the mentioned 
four genes could be due to a bias generated by the PCR amplification. However, the 
bias is low as it only eliminated a few of the positive signals. On the other hand, in 
comparison to the conventional approach, the PCR amplification method has rendered 
advantages by elevating the levels of low expression genes that are differentially 
expressed in the mutant and wild-type sibling so that they can be detected on the array.  
Indeed, from the gene expression analyses, we found that the cahz gene was expressed 
both in the ear and ICM region of the wild-type, whereas it’s expression was lost in the 
ICM region in the clo mutant (Figure 4.8 T,V). This low level difference in expression was 
picked out by the amplified method but not by the conventional method. Similarly, the 
expression of zvsg1 was very low at 18-somite stage but was notably expressed 
throughout the dorsal aorta, choroidal vascular plexus and intersegmental vessel at 
36hpf (Figure 4.10 H,I) in the wild-type. Clearly, zvsg1 is a vessel-specific gene and is 
absent in the clo mutant. However, the difference in zvsg1 transcript level between the 
wild-type and clo mutant is too low at 18-somite and will fall below the statistically set 
ratio of 1.5-fold to be scored as positive when the conventional method is employed. 
Correspondingly, genes that are differentially expressed at very low levels in the wild-
types and mutants that play potentially important roles in early developmental processes 
will not be identified by using the conventional method. Hence, the amplified method not 
only complements the conventional method but is more superior than the conventional 
method to uncover low level differentially expressed genes at early developmental 
stages. With an estimate of 100,000 predicted genes in the zebrafish genome (TIGR 
Zebrafish Gene Index), the present zebrafish Affymetrix array covers only ~1/6 of the 
predicted genes (14,900 unigenes). Along with the amazing speed of data mining and 
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growing unigenes repertoire, it is very likely that there will be more genes spotted on the 
Affymetrix array in the near future. This will render us a better tool to discover more low 
abundance genes that are essential for early developmental processes via the amplified 
approach. 
As increasing number of zebrafish mutants have been identified through large scale 
genetic screening, microarray technology is one of the most powerful tools to study 
these mutants. However, to collect enough material for the analysis of early 
developmental processes is always the limiting factor to fulfill the microarray analysis, 
and the indistinguishable morphological phenotype between wild-type and mutant at 
desired stage excludes gene expression profiling by microarray as well. Although many 
transgenic fishes that displayed specific fluorescent reporter gene distribution were 
generated to facilitate the discrimination of mutant from wild-type sibling fishes based on 
a specific fluorescence characteristics, the generation of such transgenic lines take 
about 6 months and another 6-8 months to generate the mutant line carrying 
homozygous reporter transgene. In addition, the generation of a suitable reporter 
transgenic fish may not be applicable to every mutant to distinguish between the mutant 
and wild-type siblings at a desired developmental stage. Our single embryo approach 
described here bypasses the requirement of transgenic fish and can be applied on any 
mutants without any restrictions. The results demonstrated that differentially expressed 
target genes could be successfully identified through the single embryo approach, and 
the comparison between two methods show that the amplification method is not only a 
substitution, but also the reinforcement of traditional method.  
4.3.2 Newly Identified Hematopoietic and Vascular Genes  
From our microarray study, we confirmed that 22 previously known zebrafish 
hematopoietic and vascular endothelial cell genes and 18 newly identified hematopoietic 
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and vascular endothelial cell related genes were down-regulated in the clo mutant.  
Sequence and expression pattern analyses revealed that these novel genes are 
assigned to almost all different blood lineage cells, demonstrating the whole embryo 
microarray was nondiscriminatory and is a valuable tool to identify tissue specific genes. 
However, with a little surprise, we could not found any genes up-regulated in the cloche 
mutant. This result might favor the argument that the function of the cloche gene during 
hematopoiesis and vasculogenesis was transcriptional activation, and not suppression.  
4.3.2.1 Erythroid Lineage  
Genes in this group were cpo, cahz, znfl2, cldn g and Dr.16206. cpo is a mitochondrial 
enzyme that catalyze coproporphyrinogen III to protoporphyrinogen IX during heme 
synthesis (Ibraham et al., 1983); likewise, another gene cahz is an enzyme too, which is 
involved in carbon dioxide transportation (Henry and Swenson, 2000). Hence, the 
abundance of their expression in the red blood cells was indubitable. The third gene, 
znfl2, which contains six tandem zinc-finger motifs at the C-termius of the protein, falls 
into the kruppel-type zinc-finger (ZNF) –containing protein super-family known to play an 
essential role in cell differentiation, development, and tumorgenesis (Kaczynski et al., 
2003). Although not closely related to either the zebrafish erythrocyte kruppel-like family 
(eklf) or blood island-enriched kruppel-like factor (biklf) (Kawahara and Dawid, 2001; 
Oates et al., 2001), nonetheless, its erythrocyte-restricted expression suggests that znfl2 
may be involved in erythroid lineage development. cldn g is a member of the large family 
of claudin proteins that has been shown to play a pivotal role in the barrier functions of 
tight junctions in epithelial and endothelial cellular sheets (Kollmar et al., 2001; Turksen 
and Troy, 2004). Interestingly, recent studies have suggested that claudin proteins are 
also implicated in regulation of cell adhesion and migration (Tiwari-Woodruff et al., 2001). 
Given its erythrocyte-enriched expression, we speculate that cldn g may participate in 
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cell adhesion and migration of erythrocyte during zebrafish erythropoiesis. The last gene, 
Dr.16206, did not exhibit specific expression pattern through our in situ hybridization 
examination. However, a sequence blast revealed that it shared about 50% identity to 
mouse coagulation factor XIII, which is an important substance for the blood clotting and 
maintenance of normal homeostasis. Therefore, the function of Dr.16206 in zebrafish is 
very likely to be also involved in clotting process. 
4.3.2.2 Myeloid Lineage 
Two genes, mmp13 and ncf1, displayed a myeloid specific expression pattern from 
WISH analyses. mmp13 belongs to the collagenase subfamily of matrix 
metalloproteinase that can degrade the main protein components of extracellular matrix 
(Leeman et al., 2002). Recent studies on mmp13-null mice demonstrated that MMP13 
played an important role in the development of growth plate cartilage and in 
endochondral ossification (Inada et al., 2004; Stickens et al., 2004). However, our result 
shows that mmp13 is expressed specifically in the primitive macrophage during 
zebrafish early development, raising the possibility that it may be involved in the 
maturation and migration of primitive macrophage. Another gene, ncf1, as its name 
implied, is expressed in neutrophils and serves as a component of the NADPH oxidase 
complex, which is the key player in the phagocyte-mediated antimicrobial or 
proinflammatory events (Babior et al., 2002). The deficiency of this gene in human 
causes chronic granulomatous disease (Francke et al., 1990). Therefore, ncf1 can be 
acted as an early neutrophil marker in zebrafish granulopoiesis.  
4.3.2.3 Vascular Endothelial Cell 
Genes, dusp5, zvsg1, aqp8 and yrk, are potential candidates involved in vasculogenesis. 
dusp5 is a member of dual specificity phosphatase or mitogen-activated protein kinase 
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phosphatase family that is capable of removing phosphate group on both tyrosine and 
serine or threonine residues on the same protein (Kwak and Dixon, 1995; Farooq and 
Zhou, 2004). Although recent study has indicated that human DUSP5 suppresses the 
growth of several types of human cancer cells in a p53-dependent manner (Ueda et al., 
2003), its main substrate and physiological function is poorly defined. Our preliminary 
result shows that the dusp5 may regulate vascular endothelial cell development. zvsg1 
is a vessel-specific gene that encodes a novel protein without any notable domain. 
Given the fact that no mammalian homologues of this gene can be found in GeneBank, 
we think it may be a gene exclusively expressed in zebrafish. Nevertheless, its late 
vessel-specific expression suggests that this molecule may play a role in angiogenesis. 
aqp8 belongs to the major intrinsic protein superfamiliy of water-transporting channel 
(Koyama et al., 1998). In mammals, it is widely expressed in many organs, including 
gastrointestinal tract, testes, liver, heart and kidney (Elkjaer et al., 2001; Calamita et al., 
2001; Garcia et al., 2001), but its function in hematopoiesis and vasculargenesis has not 
been addressed so far. The vessel-specific expression of aqp8 in zebrafish embryo 
indicated its veiled function in early vessel development. The last gene in this group, yrk, 
is a kinase with SH2 and SH3 domain (Sudol et al., 1993). Although the expression of 
this gene in zebrafish did not show any specific pattern in hematopoietic or vascular 
tissues, its mammalian homologues do have expression in the hematopoietic tissues 
(Sudol et al., 1993). In addition, consistence with our result, Gerhard J. Weber et al also 
found that yrk fell into the cluster of vascular gene in their microarray analysis (Weber et 
al., 2005), suggesting its function in vasculagenesis.  
Taken all together, we found that 11 genes were involved in the hematopoietic or 
vascular development from the sequence and expression analyses. However, we still 
have another 7 novel genes without any known functional cues. Although a possible 
reason for this could be the general effects of these genes on zebrafish development, 
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the more likely reason is the lack of full-length sequence of these genes, and indeed, it is 
very true for zvsg1 and ncf1. Initially, we started our expression analysis using partial 
cDNA sequences as probes; these two genes were omitted from our screening for the 
reason of the low signal intensity with very high background. Fortunately, we were able 
to clone the full-length of zvsg1 and ncf1 by using RACE, and these full-length clones 
allowed us to clearly view the expression of zvsg1 in the blood vessels and ncf1 in the 
myeloid cells. Hence, we believe that we can find out the potential functions of these 7 
novel genes when their full-length clones are made available. 
4.4 Conclusion and Future Work 
We developed a new single embryo approach that facilitated the gene expression profile 
analysis for limited starting material. Combined with conventional approach, we have 
successfully identified 22 well-known hematopoietic and vascular endothelial related 
genes and 18 novel genes that were down-regulated in the cloche mutant using the 
Affymetrix array. Sequence and gene expression analyses revealed that 11 novel genes 
may be involved in the development of different hematopoietic and endothelial cells. In 
the future, functional analysis using full-length mRNA over-expression and morpholino 







A. Protein alignment of zebrafish AQP8 with human AQP8 and mouse AQP8. 
 
 





C. Protein alignment of zebrafish similar to embryonic transglutaminase with human 









E. Protein alignment of zebrafish CPO with human CPO and mouse CPO. 
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J. Protein alignment of zebrafish ZNFL2 with human zinc finger protein 41 and mouse 
zinc finger protein 248. 
 
Figure 4.11 Protein Sequence Alignments of 9 Zebrafish Affymetrix Array Targets 
with their Mammalian Homologues.  
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Table 4.1 Down-Regulated Clones Identified by Amplification Method 
 
Category Ia Category IIb 
AFFX GENE ID 
(Unigene ID) Gene  
AFFX GENE ID 
(Unigene ID) Gene  
Dr.25422.1.S1_s_at αe1-globin Dr.8153.1.S1_at cldn g 
Dr.1450.1.S1_at αe3-globin Dr.10314.1.S1_a_at mmp13 
DrAffx.1.85.S1_s_at βe1-globin Dr.12726.1.S1_at yrk 
DrAffx.2.15.S1_at βe2-globin Dr.6834.1.A1_at cpo 
DrAffx.2.19.S1_at βe3-globin Dr.3201.1.S1_at znfl2 
Dr.355.1.S1_at gata1 Dr.5365.1.A1_at dusp5 
Dr.20971.1.S2_at band3 Dr.2973.1.A1_at ncf1 
Dr.2166.1.S1_at urod Dr.450.1.S1_at cahz 
Dr.5053.1.S1_at klf4 Dr.6885.1.A1_at Dr.6885 
Dr.8180.1.S1_at alas2 Dr.9655.1.A1_at Dr.9655(zvsg1) 
Dr.8039.1.S2_at flk1 Dr.11977.1.A1_at Dr.11977 
Dr.26421.1.A1_at fli1 Dr.25117.1.S1_at Dr.25117 
Dr.8065.1.S1_at lmo2 Dr.25630.1.S1_at Dr.25630 
Dr.1458.1.S1_at scl   
DrAffx.1.39.S1_at hdr   
Dr.7612.1.A1_at spi1   

























































































































































































































































































































































































































































































































































































































































Table 4.3 Summary of Confirmed Target Clones 
 
AFFX GENE ID 
(Unigene ID) Gene  Amplified Method Standard Method 
Dr.25422.1.S1_s_at αe1-globin + + 
Dr.1450.1.S1_at αe3-globin + + 
DrAffx.1.85.S1_s_at βe1-globin + + 
DrAffx.2.15.S1_at βe2-globin + + 
DrAffx.2.19.S1_at βe3-globin + + 
Dr.355.1.S1_at gata1 + + 
Dr.20971.1.S2_at band3 + + 
Dr.2166.1.S1_at urod + + 
Dr.5053.1.S1_at klf4 + + 
Dr.8180.1.S1_at alas2 + + 
Dr.8039.1.S2_at flk1 + + 
Dr.26421.1.A1_at fli1 + + 
Dr.8065.1.S1_at lmo2 + + 
Dr.1458.1.S1_at scl + + 
DrAffx.1.39.S1_at hdr + + 
Dr.7612.1.A1_at spi1 + + 
Dr.8064.1.S1_at drl + + 
Dr.8106.1.S1_at cmyb + + 
Dr.8122.1.S1_a_at ikaros - + 
Dr.12704.1.A1_at plexinD1 - + 
Dr.3269.1.S1_at hhex - + 
Dr.3027.1.S1_at band4.1 - + 
Dr.8153.1.S1_at cldn g + + 
Dr.10314.1.S1_a_at mmp13 + + 
Dr.12726.1.S1_at yrk + + 
Dr.6834.1.A1_at cpo + + 
Dr.3201.1.S1_at znfl2 + + 
Dr.5365.1.A1_at dusp5 + + 
Dr.2973.1.A1_at ncf1 + + 
Dr.11977.1.A1_at Dr.11977 + + 
Dr.450.1.S1_at cahz + - 
Dr.6885.1.A1_at Dr.6885 + - 
Dr.9655.1.A1_at Dr.9655(zvsg1) + - 
Dr.25117.1.S1_at Dr.25117 + - 
Dr.25630.1.S1_at Dr.25630 + - 
Dr.916.1.S1_at aquaporin8 - + 
Dr.1870.1.A1_at Dr.1870 - + 
Dr.14448.1.A1_at Dr.14448 - + 
Dr.14553.1.A1_at Dr.14553 - + 
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